OTHER PUBLICATIONS


DOWNLOAD TITLE AUTHORS
Romosozumab Treatment in Postmenopausal Women with Osteoporosis F. Cosman, D. B. Crittenden, J. D. Adachi, N. Binkley, E. Czerwinski, S. Ferrari, L. C. Hofbauer, E. Lau, E. M. Lewiecki, A. Miyauchi, C. A. F. Zerbini, C. E. Milmont, L. Chen, J. Maddox, P. D. Meisner, C. Libanati, A. Grauer
Possibilities for Implementing Fracture Liaison Service in Poland in the Light of a Visit to Glasgow Western Infirmary J. Amarowicz, E. Czerwiński
Relationship between total hip (TH) BMD T-score and incidence of nonvertebral fracture (NVFX) with up to 10 years of Denosumab (Dmab) treatment S. Ferrari, S. Adami, J. P. Brown, F. Cosman, E. Czerwiński, L. H. de Gregório, J. Malouf, J.-Y. Reginster, N. S. Daizadeh, A. Wang, R. B. Wagman, E. M. Lewiecki
Cost-effectiveness Analysis of Treatment of Osteoporotic Fractures in Relation to FRAX Algorithm in a Sample of Polish Population J. Amarowicz, D. Bolisęga, J. Rutkowski, A. Kumorek, E. Czerwiński
Relationship Between Total Hip BMD T-Score and Incidence of Nonvertebral Fracture with up to 8 Years of Denosumab Treatment S. Ferrari, C. Libanati, C. J. F. Lin, S. Adami, J. P. Brown, F. Cosman, E. Czerwinski, L. H. de Gregório, J. Malouf, J.-Y. Reginster, N. S. Daizadeh, A. Wang, R. B. Wagman, E. M. Lewiecki
A 24-Month Study Evaluating the Efficacy and Safety of Denosumab for the Treatment of Men With Low Bone Mineral Density: Results From the ADAMO Trial B. L. Langdahl, C. S. Teglbjærg, P.-R. Ho, R. Chapurlat, E. Czerwinski, D. L. Kendler, J.-Y. Reginster, A. Kivitz, E. M. Lewiecki, P. D. Miller, M. A. Bolognese, M. R. McClung, H. G. Bone, Ö. Ljunggren, B. Abrahamsen, U. Gruntmanis, Y.-C. Yang, R. B. Wagman, F. Mirza, S. Siddhanti, E. Orwoll
Accumulation of risk factors associated with poor bone health in older adults J. Zhang, K. Jameson, A. A. Sayer, S. Robinson, C. Cooper, E. Dennison
Drug utilization in patients with OA: a population-based study N. Wilson, L. Sanchez-Riera, R. Morros, A. Diez-Perez, M. K. Javaid, C. Cooper, N. K. Arden, D. Prieto-Alhambra
Individuals With Type 2 Diabetes Mellitus Are at an Increased Risk of Gout But This Is Not Due to Diabetes J. M. A. Wijnands, C. M. P. G. van Durme, J. H. M. Driessen, A. Boonen, C. Klop, B. Leufkens, C. Cooper, C. D. A. Stehouwer, F. de Vries
Identification of risk factors for hospital admission using multiple-failure survival models: a toolkit for researchers L. D. Westbury, H. E. Syddall, S. J. Simmonds, C. Cooper, A. A. Sayer
Heavy manual work throughout the working lifetime and muscle strength among men at retirement age K. Walker-Bone, S. D’Angelo, H. E. Syddall, K. T. Palmer, C. Cooper, D. Coggon, A. A. Sayer
Chronic widespread bodily pain is increased among individuals with history of fracture: findings from UK Biobank K. Walker-Bone, N. C. Harvey, G. Ntani, T. Tinati, G. T. Jones, B. H. Smith, G. J. Macfarlane, C. Cooper
Greater access to fast-food outlets is associated with poorer bone health in young children C. Vogel, C. Parsons, K. Godfrey, S. Robinson, N. C. Harvey, H. Inskip, C. Cooper, J. Baird
Education and the Relationship Between Supermarket Environment and Diet C. Vogel, G. Ntani, H. Inskip, M. Barker, S. Cummins, C. Cooper, G. Moon, J. Baird
Secular trends in fracture incidence in the UK between 1990 and 2012 R. Y. van der Velde, C. E. Wyers, E. M. Curtis, P. P. M. M. Geusens, J. P. W. van den Bergh, F. de Vries, C. Cooper, T. P. van Staa, N. C. Harvey
Impact of clinical osteoarthritis of the hip, knee and hand on self- rated health in six European countries: the European Project on OSteoArthritis N. M. van Schoor, S. Zambon, M. V. Castell, C. Cooper, M. Denkinger, E. M. Dennison, M. H. Edwards, F. Herbolsheimer, S. Maggi, M. Sánchez-Martinez, N. L. Pedersen, R. Peter, L. A. Schaap, J. J. M. Rijnhart, S. van der Pas, D. J. H. Deeg
Availability and use of neighborhood resources by older people with osteoarthritis: Results from the European Project on OSteoArthritis S. van der Pas, L. A. Schaap, M. V. Castell, C. Cooper, M. Denkinger, M. H. Edwards, F. Herbolsheimer, S. Maggi, M. Sánchez-Martinez, N. L. Pedersen, R. Peter, S. Zambon, S. B. Wiegersma, J. Dekker, E. M. Dennison, D. J. H. Deeg
Understanding poor health behaviours as predictors of different types of hospital admission in older people: findings from the Hertfordshire Cohort Study H. E. Syddall, L. D. Westbury, S. J. Simmonds, S. Robinson, C. Cooper, A. A. Sayer
Self-reported walking speed: a useful marker of physical performance among community-dwelling older people? H. E. Syddall, L. D. Westbury, C. Cooper, A. A. Sayer
Clinical trials of new drugs for the treatment of rheumatoid arthritis: focus on early disease J. S. Smolen, S. Collaud Basset, M. Boers, F. Breedveld, C. J Edwards, T. K. Kvien, P. Miossec, T. Sokka-Isler, R. F. van Vollenhoven, E. C. Abadie, O. Bruyère, C. Cooper, H. Mäkinen, T. Thomas, P. Tugwell, J.-Y. Reginster, on behalf of the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO)
Grip strength among community-dwelling older people predicts hospital admission during the following decade S. J. SIMMONDS, H. E. SYDDALL, L. D. WESTBURY, R. M. DODDS, C. COOPER, A. A. SAYER
Bisphosphonate drug holidays: we reap what we sow S. L. Silverman, J. D. Adachi, E. Dennison, the International Osteoporosis Foundation Epidemiology/Quality of Life Working Group
International management of bone health in glucocorticoid-exposed individuals in the observational GLOW study S. Silverman, J. Curtis, K. Saag, J. Flahive, J. Adachi, F. Anderson, R. Chapurlat, C. Cooper, A. Diez-Perez, S. Greenspan, F. Hooven, A. Le Croix, L. March, J. C. Netelenbos, J. Nieves, J. Pfeilschifter, M. Rossini, C. Roux, E. Siris, N. Watts, J. Compston
Effects of Dairy Products Consumption on Health: Benefits and Beliefs—A Commentary from the Belgian Bone Club and the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases S. Rozenberg, J.-J. Body, O. Bruyère, P. Bergmann, M. L. Brandi, C. Cooper, J.-P. Devogelaer, E. Gielen, S. Goemaere, J.-M. Kaufman, R. Rizzoli, J.-Y. Reginster
Modifiable early-life risk factors for childhood adiposity and overweight: an analysis of their combined impact and potential for prevention S. M. Robinson, S. R. Crozier, N. C. Harvey, B. D. Barton, C. M. Law, K. M. Godfrey, C. Cooper, H. M. Inskip
Can trained volunteers make a difference at mealtimes for older people in hospital? A qualitative study of the views and experience of nurses, patients, relatives and volunteers in the Southampton Mealtime Assistance Study J. Robison, A. L. Pilgrim, G. Rood, N. Diaper, M. Elia, A. A. Jackson, C. Cooper, A. A. Sayer, S. Robinson, H. C. Roberts
A review of the methods used to define glucocorticoid exposure and risk attribution when investigating the risk of fracture in a rheumatoid arthritis population D. E. Robinson, E. M. Dennison, C. Cooper, T. P. van Staa, W. G. Dixon
The Association of Grip Strength With Severity and Duration of Parkinson’s: A Cross-Sectional Study H. C. Roberts, H. E. Syddall, J. W. Butchart, E. L. Stack, C. Cooper, A. A. Sayer
Limited exposure to ambient ultraviolet radiation and 25-hydroxyvitamin D levels: a systematic review S. A. Rice, M. Carpenter, A. Fityan, L. M. Vearncombe, M. Ardern-Jones, A. A. Jackson, C. Cooper, J. Baird, E. Healy
Socio-economic status and the risk of developing hand, hip or knee osteoarthritis: a region-wide ecological study C. Reyes, M. Garcia-Gil, J. M. Elorza, L. Mendez-Boo, E. Hermosilla, M. K. Javaid, C. Cooper, A. Diez-Perez, N. K. Arden, B. Bolibar, R. Ramos, D. Prieto-Alhambra
Real-Life and RCT Participants: Alendronate Users Versus FITs’ Trial Eligibility Criterion C. Reyes, A. Pottegård, P. Schwarz, M. K. Javaid, T. P. Van Staa, C. Cooper, A. Diez-Perez, B. Abrahamsen, D. Prieto-Alhambra
Association Between Overweight and Obesity and Risk of Clinically Diagnosed Knee, Hip, and Hand Osteoarthritis C. Reyes, K. M. Leyland, G. Peat, C. Cooper, N. K. Arden, D. Prieto-Alhambra
The position of strontium ranelate in today’s management of osteoporosis J.-Y. Reginster, M.-L. Brandi, J. Cannata-Andía, C. Cooper, B. Cortet, J.-M. Feron, H. Genant, S. Palacios, J. D. Ringe, R. Rizzoli
Recommendations for the conduct of clinical trials for drugs to treat or prevent sarcopenia J.-Y. Reginster, C. Cooper, R. Rizzoli, J. A. Kanis, G. Appelboom, I. Bautmans, H. A. Bischoff-Ferrari, M. Boers, M. L. Brandi, O. Bruyère, A. Cherubini, B. Flamion, R. A. Fielding, A. I. Gasparik, L. Van Loon, E. McCloskey, B. H. Mitlak, A. Pilotto, S. Reiter-Niesert, Y. Rolland, Y. Tsouderos, M. Visser, A. J. Cruz-Jentoft
Optimizing the management of osteoarthritis—Transitioning evidence-based guidelines into practical guidance for real-world clinical practice J.-Y. Reginster, C. Cooper
Recommendations for an update of the 2010 European regulatory guideline on clinical investigation of medicinal products used in the treatment of osteoarthritis and reflections about related clinically relevant outcomes: expert consensus statement J.-Y. Reginster, S. Reiter-Niesert, O. Bruyère, F. Berenbaum, M.-L. Brandi, J. Branco, J.-P. Devogelaer, G. Herrero-Beaumont, J. Kanis, S. Maggi, E. Maheu, P. Richette, R. Rizzoli, C. Cooper
Comments on the discordant recommendations for the use of symptomatic slow-acting drugs in knee osteoarthritis J.-Y. Reginster, C. Cooper, M. Hochberg, J.-P. Pelletier, R. Rizzoli, J. Kanis, E. Abadie, E. Maheu, M. L. Brandi, J.-P. Devogelaer, J. Branco, G. Herrero-Beaumont, P. D’Hooghe, O. Bruyère
Publication outcomes of the abstracts presented at the 2011 European Congress on Osteoporosis, Osteoarthritis and Musculo-Skeletal Diseases (ECCEO-IOF11) V. Rabenda, O. Bruyère, C. Cooper, R. Rizzoli, F. Buckinx, A. Quabron, J.-Y. Reginster
Hormone replacement therapy and mid-term implant survival following knee or hip arthroplasty for osteoarthritis: a population-based cohort study D. Prieto-Alhambra, M. K. Javaid, A. Judge, J. Maskell, C. Cooper, N. K. Arden, on behalf of the COASt Study Group
Ankylosing spondylitis confers substantially increased risk of clinical spine fractures: a nationwide case-control study D. Prieto-Alhambra, J. Muñoz-Ortego, F. De Vries, D. Vosse, N. K. Arden, P. Bowness, C. Cooper, A. Diez-Perez, P. Vestergaard
MEASURING APPETITE WITH THE SIMPLIFIED NUTRITIONAL APPETITE QUESTIONNAIRE IDENTIFIES HOSPITALISED OLDER PEOPLE AT RISK OF WORSE HEALTH OUTCOMES A. L. PILGRIM, D. BAYLIS, K. A. JAMESON, C. COOPER, A. A. SAYER, S. M. ROBINSON, H. C. ROBERTS
Efficacy and safety of oral NSAIDs and analgesics in the management of osteoarthritis: Evidence from real-life setting trials and surveys J.-P. Pelletier, J. Martel-Pelletier, F. Rannou, C. Cooper
Diacerein: Benefits, Risks and Place in the Management of Osteoarthritis. An Opinion-Based Report from the ESCEO K. Pavelka, O. Bruyère, C. Cooper, J. A. Kanis, B. F. Leeb, E. Maheu, J. Martel-Pelletier, J. Monfort, J.-P. Pelletier, R. Rizzoli, J.-Y. Reginster
Skeletal muscle morphology in sarcopenia defined using the EWGSOP criteria: findings from the Hertfordshire Sarcopenia Study (HSS) H. P. Patel, M. C. White, L. Westbury, H. E. Syddall, P. J. Stephens, G. F. Clough, C. Cooper, A. A. Sayer
How well do radiographic, clinical and self-reported diagnoses of knee osteoarthritis agree? Findings from the Hertfordshire cohort study C. Parsons, M. Clynes, H. Syddall, D. Jagannath, A. Litwic, S. van der Pas, C. Cooper, E. M. Dennison, M. H. Edwards, the EPOSA research group
Health and Employment after Fifty (HEAF): a new prospective cohort study K. T. Palmer, K. Walker-Bone, E. C. Harris, C. Linaker, S. D’Angelo, A. A. Sayer, C. R. Gale, M. Evandrou, T. van Staa, C. Cooper, D. Coggon
Relationships between bone geometry, volumetric bone mineral density and bone microarchitecture of the distal radius and tibia with alcohol consumption J. Paccou, M. H. Edwards, K. Ward, K. Jameson, R. Moon, E. Dennison, C. Cooper
Ischemic heart disease is associated with lower cortical volumetric bone mineral density of distal radius J. Paccou, M. H. Edwards, K. A. Ward, K. A. Jameson, C. L. Moss, N. C. Harvey, E. M. Dennison, C. Cooper
Bone Microarchitecture in Men and Women with Diabetes: The Importance of Cortical Porosity J. Paccou, K. A. Ward, K. A. Jameson, E. M. Dennison, C. Cooper, M. H. Edwards
Diet quality across early childhood and adiposity at 6 years: the Southampton Women’s Survey H. Okubo, S. R. Crozier, N. C. Harvey, K. M. Godfrey, H. M. Inskip, C. Cooper, S. M. Robinson, SWS Study Group
Wellbeing and Arthritis Incidence: the Survey of Health, Ageing and Retirement in Europe J. A. Okely, C. Cooper, C. R. Gale
Maternal and early life factors of tooth emergence patterns and number of teeth at one and two years of age G. Ntani, P. F. Day, J. Baird, K. M. Godfrey, S. M. Robinson, C. Cooper, H. M. Inskip, the Southampton Women’s Survey Study Group
A study of common Mendelian disease carriers across ageing British cohorts: meta-analyses reveal heterozygosity for alpha 1-antitrypsin deficiency increases respiratory capacity and height T.-L. North, Y. Ben-Shlomo, C. Cooper, I. J. Deary, J. Gallacher, M. Kivimaki, M. Kumari, R. M. Martin, A. Pattie, A. A. Sayer, J. M. Starr, A. Wong, D. Kuh, S. Rodriguez, I. N. M. Day
Changes in health in England, with analysis by English regions and areas of deprivation, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013 J. N. Newton, A. D. M. Briggs, C. J. L. Murray, D. Dicker, K. J. Foreman, H. Wang, M. Naghavi, M. H. Forouzanfar, S. Lockett Ohno, R. M. Barber, T. Vos, J. D. Stanaway, J. C. Schmidt, A. J. Hughes, D. F. J. Fay, R. Ecob, C; Gresser, M. McKee, H. Rutter, I. Abubakar, R. Ali, H. R. Anderson, A. Banerjee, D. A. Bennett, E. Bernabé, K. S. Bhui, S. M. Biryukov, R. R. Bourne, C. E. G. Brayne, N. G. Bruce, T. S. Brugha, M. Burch, S. Capewell, D. Casey, R. Chowdhury, M. M. Coates, C. Cooper, J. A. Critchley, P. I. Dargan, M. K. Dherani, P. Elliott, M. Ezzati, K. A. Fenton, M. S. Fraser, T. Fürst, F. Greaves, M. A. Green, D. J. Gunnell, B. M. Hannigan, R. J. Hay, S. I. Hay, H. Hemingway, H. J. Larson, K. J. Looker, R. Lunevicius, R. A. Lyons, W. Marcenes, A. J. Mason-Jones, F. E. Matthews, H. Moller, M. E. Murdoch, C. R. Newton, N. Pearce, F. B. Piel, D. Pope, K. Rahimi, A. Rodriguez, P. Scarborough, A. E. Schumacher, I. Shiue, L. Smeeth, A. Tedstone, J. Valabhji, H. C. Williams, C. D. A. Wolfe, A. D. Woolf, A. C. J. Davis
Contribution of common non-synonymous variants in PCSK1 to body mass index variation and risk of obesity: a systematic review and meta-analysis with evidence from up to 331 175 individuals K. T. Nead, A. Li, M. R. Wehner, B. Neupane, S. Gustafsson, A. Butterworth, J. C. Engert, A. D. Davis, R. A. Hegele, R. Miller, M. den Hoed, K.-T. Khaw, T. O. Kilpeläinen, N. Wareham, T. L. Edwards, G. Hallmans, T. V. Varga, S. L. R. Kardia, J. A. Smith, W. Zhao, J. D. Faul, D. Weir, J. Mi, B. Xi, S. Canizales Quinteros, C. Cooper, A. A. Sayer, K. Jameson, A. Grøntved, M. Fornage, S. Sidney, C. L. Hanis, H. M. Highland, H.-U. Häring, M. Heni, J. Lasky-Su, S. T. Weiss, G. S. Gerhard, C. Still, M. M. Melka, Z. Pausova, T. Paus, S. F. A. Grant, H. Hakonarson, R. Arlen Price, K. Wang, A. Scherag, J. Hebebrand, A. Hinney, B. Japan, AGEN-BMI, GIANT Consortium, P. W. Franks, T. M. Frayling, M. I. McCarthy, J. N. Hirschhorn, R. J. Loos, E. Ingelsson, H. C. Gerstein, S. Yusuf, J. Beyene, S. S. Anand, D. Meyre
Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990–2013: quantifying the epidemiological transition GBD 2013 DALYs and HALE Collaborators
Vitamin D and bone development R. J. Moon, N. C. Harvey, J. H. Davies, C. Cooper
Validity of parental recall of children’s fracture: implications for investigation of childhood osteoporosis R. J. Moon, A. Lim, M. Farmer, A. Segaran, N. M. P. Clarke, N. C. Harvey, C. Cooper, J. H. Davies
Tracking of 25-hydroxyvitamin D status during pregnancy: the importance of vitamin D supplementation R. J. Moon, S. R. Crozier, E. M. Dennison, J. H. Davies, S. M. Robinson, H. M. Inskip, K. M. Godfrey, C. Cooper, N. C. Harvey
Longitudinal changes in lean mass predict pQCT measures of tibial geometry and mineralisation at 6–7 years R. J. Moon, Z. A. Cole, S. R. Crozier, E. M. Curtis, J. H. Davies, C. L. Gregson, S. M. Robinson, E. M. Dennison, K. M. Godfrey, H. M. Inskip, C. Cooper, N. C. Harvey, The Southampton Women's Survey Study Group
Influence of maternal vitamin D status on obstetric outcomes and the foetal skeleton R. J. Moon, N. C. Harvey, C. Cooper
Ethnic and geographic variations in the epidemiology of childhood fractures in the United Kingdom R. J. Moon, N. C. Harvey, E. M. Curtis, F. de Vries, T. van Staa, C. Cooper
Differences in childhood adiposity influence upper limb fracture site R. J. Moon, A. Lim, M. Farmer, A. Segaran, N. M. P. Clarke, E. M. Dennison, N. C. Harvey, C. Cooper, J. H. Davies
Life-course approach to nutrition P. J. Mitchell, C. Cooper, B. Dawson-Hughes, C. M. Gordon, R. Rizzoli
Metabolomic Identication of a Novel Pathway of Blood Pressure Regulation Involving Hexadecanedioate C. Menni, D. Graham, G. Kastenmüller, N. H. J. Alharbi, S. M. D. Alsanosi, M. McBride, M. Mangino, P. Titcombe, S.-Y. Shin, M. Psatha, T. Geisendorfer, A. Huber, A. Peters, R. Wang-Sattler, T. Xu, M. J. Brosnan, J. Trimmer, C. Reichel, R. P. Mohney, N. Soranzo, M. H. Edwards, C. Cooper, A. C. Church, K. Suhre, C. Gieger, A. F. Dominiczak, T. D. Spector, S. Padmanabhan, A. M. Valdes
FRAX-based assessment and intervention thresholds— an exploration of thresholds in women aged 50 years and older in the UK E. McCloskey, J. A. Kanis, H. Johansson, N. Harvey, A. Odén, A. Cooper, C. Cooper, R. M. Francis, D. M. Reid, D. Marsh, P. Selby, F. Thompson, S. Hewitt, J. Compston
Incident type 2 diabetes and hip fracture risk: a population-based matched cohort study D. Martinez-Laguna, C. Tebe, M. K. Javaid, X. Nogues, N. K. Arden, C. Cooper, A. Diez-Perez, D. Prieto-Alhambra
Does Combined Clinical and Ultrasound Assessment Allow Selection of Individuals With Rheumatoid Arthritis for Sustained Reduction of Anti–Tumor Necrosis Factor Therapy? J. L. MARKS, C. R. HOLROYD, B. D. DIMITROV, R. D. ARMSTRONG, A. CALOGERAS, C. COOPER, B. K. DAVIDSON, E. M. DENNISON, N. C. HARVEY, C. J. EDWARDS
Structural and Functional Changes of the Invariant NKT Clonal Repertoire in Early Rheumatoid Arthritis S. Mansour, A. S. Tocheva, J. P. Sanderson, L. M. Goulston, H. Platten, L. Serhal, C. Parsons, M. H. Edwards, C. H. Woelk, P. T. Elkington, T. Elliott, C. Cooper, C. J. Edwards, S. D. Gadola
Antenatal blood pressure for prediction of pre-eclampsia, preterm birth, and small for gestational age babies: development and validation in two general population cohorts C. Macdonald-Wallis, R. J. Silverwood, B. L. de Stavola, H. Inskip, C. Cooper, K. M. Godfrey, S. Crozier, A. Fraser, S. M. Nelson, D. A. Lawlor, K. Tilling
Non-invasive Assessment of Lower Limb Geometry and Strength Using Hip Structural Analysis and Peripheral Quantitative Computed Tomography: A Population-Based Comparison A. E. Litwic, M. Clynes, H. J. Denison, K. A. Jameson, M. H. Edwards, A. A. Sayer, P. Taylor, C. Cooper, E. M. Dennison
Obesity and the Relative Risk of Knee Replacement Surgery in Patients With Knee Osteoarthritis K. M. Leyland, A. Judge, M. K. Javaid, A. Diez-Perez, A. Carr, C. Cooper, N. K. Arden, D. Prieto-Alhambra
Increased expression of H19/miR-675 is associated with a low fat-free mass index in patients with COPD A. Lewis, J. Y. Lee, A. V. Donaldson, S. A. Natanek, S. Vaidyanathan, W. D.-C. Man, N. S. Hopkinson, A. A. Sayer, H. P. Patel, C. Cooper, H. Syddall, M. I. Polkey, P. R. Kemp
Impact of hip fracture on hospital care costs: a population-based study J. Leal, A. M. Gray, D. Prieto-Alhambra, N. K. Arden, C. Cooper, M. K. Javaid, A. Judge, The REFReSH study group
‘Making every contact count’: Evaluation of the impact of an intervention to train health and social care practitioners in skills to support health behaviour change W. Lawrence, C. Black, T. Tinati, S. Cradock, R. Begum, M. Jarman, A. Pease, B. Margetts, J. Davies, H. Inskip, C. Cooper, J. Baird, M. Barker
Statins and Risk of Lower Limb Revision Surgery: The Influence of Differences in Study Design Using Electronic Health Records From the United Kingdom and Denmark A. Lalmohamed, T. P. van Staa, P. Vestergaard, H. G. M. Leufkens, A. de Boer, P. Emans, C. Cooper, F. de Vries
A review of glucosamine for knee osteoarthritis: why patented crystalline glucosamine sulfate should be differentiated from other glucosamines to maximize clinical outcomes E. J. Kucharz, V. Kovalenko, S. Szántó, O. Bruyère, C. Cooper, J.-Y. Reginster
Pubertal timing and bone phenotype in early old age: findings from a British birth cohort study D. Kuh, S. G. Muthuri, A. Moore, T. J. Cole, J. E. Adams, C. Cooper, R. Hardy, K. A. Ward
Painful knee but not hand osteoarthritis is an independent predictor of mortality over 23 years follow-up of a population-based cohort of middle-aged women S. Kluzek, M. T. Sanchez-Santos, K. M. Leyland, A. Judge, T. D. Spector, D. Hart, C. Cooper, J. Newton, N. K. Arden
SIGN Guidelines for Scotland: BMD Versus FRAX Versus QFracture J. A. Kanis, J. Compston, C. Cooper, N. C. Harvey, H. Johansson, A. Odén, E. V. McCloskey
A systematic review of intervention thresholds based on FRAX J. A. Kanis, N. C. Harvey, C. Cooper, H. Johansson, A. Odén, E. V. McCloskey, The Advisory Board of the National Osteoporosis Guideline Group
Site-Dependent Reference Point Microindentation Complements Clinical Measures for Improved Fracture Risk Assessment at the Human Femoral Neck T. Jenkins, L. V. Coutts, S. D’Angelo, D. G. Dunlop, R. O. C. Oreffo, C. Cooper, N. C. Harvey, P. J. Thurner, the Observational Study Examining Osteoporosis (OStEO) group
Exome-wide analysis of rare coding variation identifies novel associations with COPD and airflow limitation in MOCS3, IFIT3 and SERPINA12 V. E. Jackson, I. Ntalla, I. Sayers, R. Morris, P. Whincup, J.-P. Casas, A. Amuzu, M. Choi, C. Dale, M. Kumari, J. Engmann, N. Kalsheker, S. Chappell, T. Guetta-Baranes, T. M. McKeever, C. N. A. Palmer, R. Tavendale, J. W. Holloway, A. A. Sayer, E. M. Dennison, C. Cooper, M. Bafadhel, B. Barker, C. Brightling, C. E. Bolton, M. E. John, S. G. Parker, M. F. Moffat, A. J. Wardlaw, M. J. Connolly, D. J. Porteous, B. H. Smith, S. Padmanabhan, L. Hocking, K. E. Stirrups, P. Deloukas, D. P. Strachan, I. P. Hall, M. D. Tobin, L. V. Wain
Mechanisms and evaluation of bone fragility in type 1 diabetes mellitus F. S. Hough, D. D. Pierroz, C. Cooper, S. L. Ferrari, The IOF CSA Bone and Diabetes Working Group
Placental Size Is Associated Differentially With Postnatal Bone Size and Density C. R. Holroyd, C. Osmond, D. J. P. Barker, S. M. Ring, D. A. Lawlor, J. H. Tobias, G. D. Smith, C. Cooper, N. C. Harvey
Age at introduction of solid foods and feeding difficulties in childhood: findings from the Southampton Women’s Survey J. L. Hollis, S. R. Crozier, H. M. Inskip, C. Cooper, K. M. Godfrey, S. M. Robinson, Southampton Women’s Survey Study Group
Physical Activity Patterns Among Older Adults With and Without Knee Osteoarthritis in Six European Countries F. HERBOLSHEIMER, L. A. SCHAAP, M. H. EDWARDS, S. MAGGI, Á. OTERO, E. J. TIMMERMANS, M. D. DENKINGER, S. VAN DER PAS, J. DEKKER, C. COOPER, E. M. DENNISON, N. M. VAN SCHOOR, R. PETER, THE EPOSA STUDY GROUP
Incidence and Predictors of Multiple Fractures Despite High Adherence to Oral Bisphosphonates: A Binational Population-Based Cohort Study S. Hawley, M. K. Javaid, K. H. Rubin, A. Judge, N. K. Arden, P. Vestergaard, R. Eastell, A. Diez-Perez, C. Cooper, B. Abrahamsen, D. Prieto-Alhambra
Clinical effectiveness of orthogeriatric and fracture liaison service models of care for hip fracture patients: population-based longitudinal study S. HAWLEY, M. K. JAVAID, D. PRIETO-ALHAMBRA, J. LIPPETT, S. SHEARD, N. K. ARDEN, C. COOPER, A. JUDGE, THE REFRESH STUDY GROUP
On epidemiology of fractures and variation with age and ethnicity N. C. Harvey, E. M. Curtis, R. van der Velde, R. J. Moon, J. P.W. van den Bergh, P. Geusens, F. de Vries, T. P. van Staa, C. Cooper
High-dose vitamin D supplementation does not alter bone mass or muscle function over 1 year in postmenopausal women N. C. Harvey, C. Cooper
FRAX predicts incident falls in elderly men: findings from MrOs Sweden N. C. Harvey, H. Johansson, A. Odén, M. K. Karlsson, B. E. Rosengren, Ö. Ljunggren, C. Cooper, E. McCloskey, J. A. Kanis, C. Ohlsson, D. Mellström
Developmental aspects of a life course approach to healthy ageing M. A. Hanson, C. Cooper, A. Aihie Sayer, R. J. Eendebak, G. F. Clough, J. R. Beard
Harmonising data collection from osteoarthritis studies to enable stratification: recommendations on core data collection from an Arthritis Research UK clinical studies group S. R. Kingsbury, N. Corp, F. E. Watt, D. T. Felson, T. W. O’Neill, C. A. Holt, R. K. Jones, P. G. Conaghan, Arthritis Research UK Osteoarthritis and Crystal Disease Clinical Studies Group working group, N. K. Arden
Recommendations for the conduct of efficacy trials of treatment devices for osteoarthritis: a report from a working group of the Arthritis Research UK Osteoarthritis and Crystal Diseases Clinical Studies Group D. T. Felson, A. C. Redmond, G. J. Chapman, T. O. Smith, D. F. Hamilton, R. K. Jones, C. A. Holt, M. J. Callaghan, D. J. Mason, Arthritis Research UK Osteoarthritis and Crystal Diseases Clinical Studies Groupy, P. G. Conaghan
Association Between Overweight and Obesity and Risk of Clinically Diagnosed Knee, Hip, and Hand Osteoarthritis C. Reyes, K. M. Leyland, G. Peat, C. Cooper, N. K. Arden, D. Prieto-Alhambra
The effect of vitamin D supplementation on knee osteoarthritis, the VIDEO study: a randomised controlled trial N. K. Arden, S. Cro, S. Sheard, C. J. Dore, A. Bara, S. A. Tebbs, D. J. Hunter, S. James, C. Cooper, T. W. O'Neill, A. Macgregor, F. Birrell, R. Keen
The OA Trial Bank: meta-analysis of individual patient data from knee and hip osteoarthritis trials show that patients with severe pain exhibit greater benefit from intra-articular glucocorticoids M. van Middelkoop, N. K. Arden, I. Atchia, F. Birrell, J. Chao, M. U. Rezende, R. G. W. Lambert, P. Ravaud, J. W. Bijlsma, M. Doherty, K. S. Dziedzic, L. S. Lohmander, T. E. McAlindon, W. Zhang, S. M. A. Bierma-Zeinstra
Strategies for the prevention of knee osteoarthritis E. M. Roos, N. K. Arden
Measures of hip morphology are related to development of worsening radiographic hip osteoarthritis over 6 to 13 year follow-up: the Johnston County Osteoarthritis Project A. E. Nelson, J. L. Stiller, X. A. Shi, K. M. Leyland, J. B. Renner, T. A. Schwartz, N. K. Arden, J. M. Jordan
Obesity and the Relative Risk of Knee Replacement Surgery in Patients With Knee Osteoarthritis K. M. Leyland, A. Judge, M. K. Javaid, A. Diez-Perez, A. Carr, C. Cooper, N. K. Arden, D. Prieto-Alhambra
Serum cartilage oligomeric matrix protein and development of radiographic and painful knee osteoarthritis. A community-based cohort of middle-aged women S. Kluzek, A.-C. Bay-Jensen, A. Judge, M. A. Karsdal, M. Shorthose, T. Spector, D. Hart, J. L. Newton, N. K. Arden
Predictors of Patient-Reported Pain and Functional Outcomes Over 10 Years After Primary Total Knee Arthroplasty: A Prospective Cohort Study Y. Jiang, M. T. Sanchez-Santos, A. D. Judge, D. W. Murray, N. K. Arden
High Kellgren-Lawrence Grade and Bone Marrow Lesions Predict Worsening Rates of Radiographic Joint Space Narrowing; The SEKOIA Study M. H. Edwards, C. Parsons, O. Bruyère, F. Petit Dop, R. Chapurlat, F. W. Roemer, A. Guermazi, S. Zaim, H. Genant, J.-Y. Reginster, E. M. Dennison, C. Cooper, The SEKOIA Study Group
Anti-Osteoporosis Medication Prescriptions and Incidence of Subsequent Fracture Among Primary Hip Fracture Patients in England and Wales: An Interrupted Time-Series Analysis S. Hawley, J. Leal, A. Delmestri, D. Prieto-Alhambra, N. K. Arden, C. Cooper, M. K. Javaid, A. Judge for the REFReSH Study Group
A comparison of radiographic anatomic axis knee alignment measurements and cross-sectional associations with knee osteoarthritis L. M. Goulston, M. T. Sanchez-Santos, S. D'Angelo, K. M. Leyland, D. J. Hart, T. D. Spector, C. Cooper, E. M. Dennison, D. Hunter, N. K. Arden
Maternal gestational vitamin D supplementation and offspring bone health (MAVIDOS): a multicentre, double-blind, randomised placebo-controlled trial C. Cooper, N. C. Harvey, N. J. Bishop, S. Kennedy, A. T. Papageorghiou, I. Schoenmakers, R. Fraser, S. V. Gandhi, A. Carr, S. D’Angelo, S. R. Crozier, R. J. Moon, N. K. Arden, E. M. Dennison, K. M. Godfrey, H. M. Inskip, A. Prentice, M. Z. Mughal, R. Eastell, D. M. Reid, M. K. Javaid, the MAVIDOS Study Group
Mortality rates at 10 years after metal-on-metal hip resurfacing compared with total hip replacement in England A. R. Kendal, D. Prieto-Alhambra, N. K. Arden, A. Carr, A. Judge
Can We Identify Patients with High Risk of Osteoarthritis Progression Who Will Respond to Treatment? A Focus on Biomarkers and Frailty N. Arden, P. Richette, C. Cooper, O. Bruyère, E. Abadie, J. Branco, M. L. Brandi, F. Berenbaum, C. Clerc, E. Dennison, J.-P. Devogelaer, M. Hochberg, P. D’Hooghe, G. Herrero-Beaumont, J. A. Kanis, A. Laslop, V. Leblanc, S. Maggi, G. Mautone, J.-P. Pelletier, F. Petit-Dop, S. Reiter-Niesert, R. Rizzoli, L. Rovati, E. Tajana Messi, Y. Tsouderos, J. Martel-Pelletier, J.-Y. Reginster
Painful knee but not hand osteoarthritis is an independent predictor of mortality over 23 years follow-up of a population-based cohort of middle-aged women S. Kluzek, M. T. Sanchez-Santos, K. M. Leyland, A. Judge, T. D. Spector, D. Hart, C. Cooper, J. Newton, N. K. Arden
Transfer factor, lung volumes, resistance and ventilation distribution in healthy adults S. Verbanck, A. Van Muylem, D. Schuermans, I. Bautmans, B. Thompson, W. Vincken
Low- and High-Resistance Exercise: Long-Term Adherence and Motivation among Older Adults E. Van Roie, I. Bautmans, W. Coudyzer, F. Boen, C. Delecluse
Predicting appendicular lean and fat mass with bioelectrical impedance analysis in older adults with physical function decline - The PROVIDE study A. Scafoglieri, J. Pieter Clarys, J. M. Bauer, S. Verlaan, L. Van Malderen, S. Vantieghem, T. Cederholm, C. C. Sieber, T. Mets, I. Bautmans on behalf of the Provide Study Group
Recommendations for the conduct of clinical trials for drugs to treat or prevent sarcopenia J.-Y. Reginster, C. Cooper, R. Rizzoli, J. A. Kanis, G. Appelboom, I. Bautmans, H. A. Bischoff-Ferrari, M. Boers, M. L. Brandi, O. Bruyère, A. Cherubini, B. Flamion, R. A. Fielding, A. Ildiko Gasparik, L. Van Loon, E. McCloskey, B. H. Mitlak, A. Pilotto, S. Reiter-Niesert, Y. Rolland, Y. Tsouderos, M. Visser, A. J. Cruz-Jentoft
Shifts in subsets of CD8+ T-cells as evidence of immunosenescence in patients with cancers affecting the lungs: an observational case-control study O. Okwudiri Onyema, L. Decoster, R. Njemini, L. Nuvagah Forti, I. Bautmans, M. De Waele, T. Mets
Aging-associated subpopulations of human CD8+ T-lymphocytes identified by their CD28 and CD57 phenotypes O. Okwudiri Onyema, R. Njemini, L. Nuvagah Forti, I. Bautmans, J. L. Aerts, M. De Waele, T. Mets
Chemotherapy-induced Changes and Immunosenescence of CD8+ T-Cells in Patients with Breast Cancer O. Okwudiri Onyema, L. Decoster, R. Njemini, L. Nuvagah Forti, I. Bautmans, M. De Waele, T. Mets
Load-Specific Inflammation Mediating Effects of Resistance Training in Older Persons L. Nuvagah Forti, E. Van Roie, R. Njemini, W. Coudyzer, I. Beyer, C. Delecluse, I. Bautmans
Dose-and gender-specific effects of resistance training on circulating levels of brain derived neurotrophic factor (BDNF) in community-dwelling older adults L. Nuvagah Forti, E. Van Roie, R. Njemini, W. Coudyzer, I. Beyer, C. Delecluse, I. Bautmans
The Contribution of Advanced Glycation End product (AGE) accumulation to the decline in motor function H. Drenth, S. Zuidema, S. Bunt, I. Bautmans, C. van der Schans, H. Hobbelen
Multiple myeloma induces Mcl-1 expression and survival of myeloid-derived suppressor cells K. De Veirman, J. A. Van Ginderachter, S. Lub, N. De Beule, K. Thielemans, I. Bautmans, B. O. Oyajobi, E. De Bruyne, E. Menu, M. Lemaire, I. Van Riet, K. Vanderkerken, E. Van Valckenborgh
Validity and test-retest reliability of the Stride Analyzer in people with knee osteoarthritis D. Beckwée, M. Degelaen, M. Eggermont, M. Gonzalez-Rodriguez, N. Lefeber, P. Vaes, I. Bautmans, E. Swinnen
Exercise in knee osteoarthritis: do treatment outcomes relate to bone marrow lesions? A randomized trial D. Beckwée, P. Vaes, S. Raeymaeckers, M. Shahabpour, T. Scheerlinck, I. Bautmans
Exercise in knee osteoarthritis – preliminary findings: Exercise-induced pain and health status differs between drop-outs and retainers D. Beckwée, I. Bautmans, T. Scheerlinck, P. Vaes
The Influence of Joint Loading on Bone Marrow Lesions in the Knee: A Systematic Review With Meta-analysis D. Beckwée, P. Vaes, M. Shahabpour, R. Muyldermans, N. Rommers, I. Bautmans
Development of a self-administrated quality of life questionnaire for sarcopenia in elderly subjects: the SarQoL C. Beaudart, E. Biver, J.-Y. Reginster, R. Rizzoli, Y. Rolland, I. Bautmans, J. Petermans, S. Gillain, F. Buckinx, J. Van Beveren, M. Jacquemain, P. Italiano, N. Dardenne, O. Bruyère
Effects of a Vitamin D and Leucine-Enriched Whey Protein Nutritional Supplement on Measures of Sarcopenia in Older Adults, the PROVIDE Study: A Randomized, Double-Blind, Placebo-Controlled Trial J. M. Bauer, S. Verlaan, I. Bautmans, K. Brandt, L. M. Donini, M. Maggio, M. E. T. McMurdo, T. Mets, C. Seal, S. L. Wijers, G. P. Ceda, G. De Vito, G. Donders, M. Drey, C. Greig, U. Holmbäck, M. Narici, J. McPhee, E. Poggiogalle, D. Power, A. Scafoglieri, R. Schultz, C. C. Sieber, T. Cederholm
An Administrator’s Perspective on the Organization of Physical Activity for Older Adults in Long-Term Care Facilities V. Baert, E. Gorus, K. Calleeuw, W. De Backer, I. Bautmans
Motivators and Barriers for Physical Activity in Older Adults With Osteoporosis V. Baert, E. Gorus, T. Mets, I. Bautmans
Physiotherapists’ Perceived Motivators and Barriers for Organizing Physical Activity for Older Long-Term Care Facility Residents V. Baert, E. Gorus, N. Guldemont, S. De Coster, I. Bautmans
Age-related differences in muscle recruitment and reaction-time performance P. Arnold, S. Vantieghem, E. Gorus, E. Lauwers, Y. Fierens, A. Pool-Goudzwaard, I. Bautmans
The Spanish version of the Fibromyalgia Rapid Screening Tool: translation, validity and reliability X. Torres, A. Collado, E. Gómez, A. Arias, S. Cabrera-Villalba, O. D. Messina, L. F. Vidal, P. Clark, C. Ríos, P. A. Salomón
The Discriminatory Ability of the Fibromyalgia Rapid Screening Tool (FiRST): An International Study in Spain and Four Latin American Countries A. Collado, X. Torres, O. D. Messina, L. F. Vidal, P. Clark, Carlos Ríos, E. Solé, A. Arias, S. Perrot, P. A. Salomon
Low Lean Mass Predicts Incident Fractures Independently From FRAX: a Prospective Cohort Study of Recent Retirees M. Hars, E. Biver, T. Chevalley, F. Herrmann, R. Rizzoli, S. Ferrari, A. Trombetti
Periostin action in bone N. Bonnet, P. Garnero, S. Ferrari
The role of biochemical of bone turnover markers in osteoporosis and metabolic bone disease: a consensus paper of the Belgian Bone Club E. Cavalier, P. Bergmann, O. Bruyère, P. Delanaye, A. Durnez, J.-P. Devogelaer, S. L. Ferrari, E. Gielen, S. Goemaere, J.-M. Kaufman, A. Nzeusseu Toukap, J.-Y. Reginster, A.-F. Rousseau, S. Rozenberg, A. J. Scheen, J.-J. Body
Mechanisms and evaluation of bone fragility in type 1 diabetes mellitus F. S. Hough, D. D. Pierroz, C. Cooper, S. L. Ferrari, The IOF CSA Bone and Diabetes Working Group
Taxonomy of rare genetic metabolic bone disorders L. Masi, D. Agnusdei, J. Bilezikian, D. Chappard, R. Chapurlat, L. Cianferotti, J.-P. Devolgelaer, A. El Maghraoui, S. Ferrari, M. K. Javaid, J.-M. Kaufman, U. A. Liberman, G. Lyritis, P. Miller, N. Napoli, E. Roldan, S. Papapoulos, N. B. Watts, M. L. Brandi
Influence of Fatigue Loading and Bone Turnover on Bone Strength and Pattern of Experimental Fractures of the Tibia in Mice N. Bonnet, M. Gerbaix, M. Ominsky, P. Ammann, P. J. Kostenuik, S. L. Ferrari
Occupation-dependent loading increases bone strength in men E. Biver, G. Perréard Lopreno, M. Hars, B. van Rietbergen, J. P. Vallée, S. Ferrari, M. Besse, R. Rizzoli
Myostatin antibody (LY2495655) in older weak fallers: a proof-of-concept, randomised, phase 2 trial C. Becker, S. R. Lord, S. A. Studenski, S. J. Warden, R. A. Fielding, C. P. Recknor, M. C. Hochberg, S. L. Ferrari, H. Blain, E. F. Binder, Y. Rolland, S. Poiraudeau, C. T. Benson, S. L. Myers, L. Hu, Q. I. Ahmad, K. R. Pacuch, E. V. Gomez, O. Benichou on behalf of the STEADY Group
Further reductions in nonvertebral fracture rate with long-term denosumab treatment in the FREEDOM open-label extension and influence of hip bone mineral density after 3 years S. Ferrari, J. D. Adachi, K. Lippuner, C. Zapalowski, P. D. Miller, J.-Y. Reginster, O. Törring, D. L. Kendler, N. S. Daizadeh, A. Wang, C. D. O’Malley, R. B. Wagman, C. Libanati, E. M. Lewiecki
Additive Genetic Effects on Circulating Periostin Contribute to the Heritability of Bone Microstructure N. Bonnet, E. Biver, C. Durosier, T. Chevalley, R. Rizzoli, S. Ferrari
Prior ankle fractures in postmenopausal women are associated with low areal bone mineral density and bone microstructure alterations E. Biver, C. Durosier, T. Chevalley, F. R. Herrmann, S. Ferrari, R. Rizzoli
Periostin expression contributes to cortical bone loss during unloading M. Gerbaix, L. Vico, S. L. Ferrari, N. Bonnet
Critical analytical evaluation of promising markers for sarcopenia E. Cavalier, C. Beaudart, F. Buckinx, O. Bruyère, J.-Y. Reginster
The Role of Bone Marrow Fat in Skeletal Health: Usefulness and Perspectives for Clinicians J. Paccou, P. Hardouin, A. Cotten, G. Penel, B. Cortet
Trabecular Bone Score: Where are we now? V. Bousson, C. Bergot, B. Sutter, T. Thomas, S. Bendavid, C.-L. Benhamou, H. Blain, M. Brazier, V. Breuil, K. Briot, R. Chapurlat, L. Chapuis, M. Cohen Solal, P. Fardellone, J.-M. Feron, J.-B. Gauvain, M. Laroche, E. Legrand, E. Lespessailles, A. Linglart, C. Marcelli, C. Roux, J.-C. Souberbielle, F. Tremollieres, G. Weryha, B. Cortet, Groupe de Recherche et d’Information sur les Ostéoporoses (GRIO)
Gastrointestinal symptoms and association with medication use patterns, adherence, treatment satisfaction, quality of life, and resource use in osteoporosis: baseline results of the MUSIC-OS study A. Modi, S. Sen, J. D. Adachi, S. Adami, B. Cortet, A. L. Cooper, P. Geusens, D. Mellström, J. Weaver, J. P. van den Bergh, A. M. Nguyen, S. Sajjan, MUSIC-OS Study Group
Bone Samples Extracted from Embalmed Subjects Are Not Appropriate for the Assessment of Bone Quality at the Molecular Level Using Raman Spectroscopy T. Pascart, B. Cortet, C. Olejnik, J. Paccou, H. Migaud, A. Cotten, Y. Delannoy, A. During, P. Hardouin, G. Penel, G. Falgayrac
TBS and bone strength B. Cortet, V. Bousson
Comparative efficacy of tocilizumab, abatacept and rituximab after non-TNF inhibitor failure: results from a multicentre study T. Pascart, P. Philippe, E. Drumez, X. Deprez, B. Cortet, A. Duhamel, E. Houvenagel, R.-M. Flipo
Trabecular Bone Score and Osteoporotic Fractures in Obese Postmenopausal Women M.-L. Ayoub, G. Maalouf, B. Cortet, I. Legroux-Gérout, G. Zunquin, R. El Hage
Secondary prevention program for osteoporotic fractures at Lille University Hospital N. Abbad, L. Lemeunier, C. Chantelot, F. Puisieux, B. Cortet
Association between gastrointestinal events and osteoporosis treatment initiation in women diagnosed with osteoporosis in France: a retrospective analysis B. Cortet, A. Modi, J. Tang, C.-P. S. Fan, S. Sajjan, J. Papadopoulos Weaver
Doses effects of zoledronic acid on mineral apatite and collagen quality of newly-formed bone in the rat's calvaria defect C. Olejnik, G. Falgayrac, A. During, B. Cortet, G. Penel
A COMPREHENSIVE FRACTURE PREVENTION STRATEGY IN OLDER ADULTS: THE EUROPEAN UNION GERIATRIC MEDICINE SOCIETY (EUGMS) STATEMENT H. BLAIN, T. MASUD, P. DARGENT-MOLINA, F.C. MARTIN, E. ROSENDAHL, N. VAN DER VELDE, J. BOUSQUET, A. BENETOS, C. COOPER, J. A. KANIS, J.Y. REGINSTER, R. RIZZOLI, B. CORTET, M. BARBAGALLO, K.E. DREINHÖFER, B. VELLAS, S. MAGGI, T. STRANDBERG, FOR THE EUGMS FALLS AND FRACTURE INTEREST GROUP, THE INTERNATIONAL ASSOCIATION OF GERONTOLOGY AND GERIATRICS FOR THE EUROPEAN REGION (IAGG-ER), THE EUROPEAN UNION OF MEDICAL SPECIALISTS (EUMS), THE FRAGILITY FRACTURE NETWORK (FFN), THE EUROPEAN SOCIETY FOR CLINICAL AND ECONOMIC ASPECTS OF OSTEOPOROSIS AND OSTEOARTHRITIS (ESCEO), AND THE INTERNATIONAL OSTEOPOROSIS FOUNDATION (IOF)
Does low bone mineral density predict mortality? B. Cortet
Reimbursment of the serum CTX assay in France: the clinical biology nomenclature is incoherent J.-C. Souberbielle, S. Bendavid, H. Blain, V. Bousson, V. Breuil, K. Briot, R. Chapurlat, L. Chapuis, M. Cohen-Solal, P. Fardellone, J.-M. Feron, J.-B. Gauvain, M. Laroche, E. Legrand, E. Lespessailles, A. Linglart, C. Marcelli, C. Roux, B. Sutter, T. Thomas, F. Trémollières, G. Weryha, B. Cortet
Management after first-line antiresorptive treatment for postmenopausal osteoporosis J. Paccou
Lower leg arterial calcification assessed by high-resolution peripheral quantitative computed tomography is associated with bone microstructure abnormalities in women J. Paccou, M. H. Edwards, J. M. Patsch, K. A. Jameson, K. A. Ward, C. Moss, E. M. Dennison, C. Cooper
The Role of Bone Marrow Fat in Skeletal Health: Usefulness and Perspectives for Clinicians J. Paccou, P. Hardouin, A. Cotten, G. Penel, B. Cortet
Relationships between bone geometry, volumetric bone mineral density and bone microarchitecture of the distal radius and tibia with alcohol consumption J. Paccou, M. H. Edwards, K. Ward, K. Jameson, R. Moon, E. Dennison, C. Cooper
Cut-off points to identify sarcopenia according to European Working Group on Sarcopenia in Older People (EWGSOP) definition G. Bahat, A. Tufan, F. Tufan, C. Kilic, T. Selçuk Akpinar, M. Kose, N. Erten, M. Akif Karan, A. J. Cruz-Jentoft
Energy and nutrient content of food served and consumed by nursing home residents F. Buckinx, S. Allepaerts, N. Paquot, J.-Y. Reginster, C. De Cock, J. Petermans, O. Bruyère
Determinants of vitamin D supplementation prescription in nursing homes: a survey among general practitioners F. Buckinx, J. Y. Reginster, E. Cavalier, J. Petermans, C. Ricour, C. Dardenne, O. Bruyère
Relationship between frailty, physical performance and quality of life among nursing home residents: the SENIOR cohort F. Buckinx, J.-Y. Reginster, J. Petermans, J. L. Croisier, C. Beaudart, T. Brunois, O. Bruyère
Incidence of hip fracture in Brazil and the development of a FRAX model C. A. F. Zerbini, V. L. Szejnfeld, B. H. Abergaria, E. V. McCloskey, H. Johansson, J. A. Kanis
Diacerein: Benefits, Risks and Place in the Management of Osteoarthritis. An Opinion-Based Report from the ESCEO K. Pavelka, O. Bruyère, C. Cooper, J. A. Kanis, B. F. Leeb, E. Maheu, J. Martel-Pelletier, J. Monfort, J.-P. Pelletier, R. Rizzoli, J.-Y. Reginster
Burden of high fracture probability worldwide: secular increases 2010–2040 A. Odén, E. V. McCloskey, J. A. Kanis, N. C. Harvey, H. Johansson
Clinical usefulness of bone turnover marker concentrations in osteoporosis H. A. Morris, R. Eastell, N. R. Jorgesen, E. Cavalier, S. Vasikaran, S. A. P. Chubb, J. A. Kanis, C. Cooper, K. Makris on behalf of the IFCC-IOF Working Group for Standardisation of Bone Marker Assays (WG-BMA)
A Meta-Analysis of Trabecular Bone Score in Fracture Risk Prediction and Its Relationship to FRAX E. V. McCloskey, A. Odén, N. C. Harvey, W. D. Leslie, D. Hans, H. Johansson, R. Barkmann, S. Boutroy, J. Brown, R. Chapurlat, P. J. M. Elders, Y. Fujita, C.-C. Glüer, D. Goltzman, M. Iki, M. Karlsson, A. Kindmark, M. Kotowicz, N. Kurumatani, T. Kwok, O. Lamy, J. Leung, K. Lippuner, Ö. Ljunggren, M. Lorentzon, D. Mellström, T. Merlijn, L. Oei, C. Ohlsson, J. A. Pasco, F. Rivadeneira, B. Rosengren, E. Sornay-Rendu, P. Szulc, J. Tamaki, J. A. Kanis
Can we treat to target in osteoporosis? E. V. McCloskey, N. C. Harvey, J. A. Kanis
Predictive ability of heel quantitative ultrasound for incident fractures: an individual-level meta-analysis E. V. McCloskey, J. A. Kanis, A. Odén, N. C. Harvey, D. Bauer, J. González-Macias, D. Hans, S. Kaptoge, M. A. Krieg, T. Kwok, F. Marin, A. Moayyeri, E. Orwoll, C. Gluёr, H. Johansson
Cost-Effectiveness of Intervention Thresholds for the Treatment of Osteoporosis Based on FRAX in Portugal A. Marques, Ó. Lourenço, G. Ortsäter, F. Borgström, J. A. Kanis, J. A. P. da Silva
Hip Axis Length is a FRAX and Bone Density Independent Risk Factor for Hip Fracture in Women W. D. Leslie, L. M. Lix, S. N. Morin, H. Johansson, A. Odén, E. V. McCloskey, J. A. Kanis
SIGN Guidelines for Scotland: BMD Versus FRAX Versus QFracture J. A. Kanis, J. Compston, C. Cooper, N. C. Harvey, H. Johansson, A. Odén, E. V. McCloskey
A systematic review of intervention thresholds based on FRAX J. A. Kanis, N. C. Harvey, C. Cooper, H. Johansson, A. Odén, E. V. McCloskey, The Advisory Board of the National Osteoporosis Guideline Group
Intervention Thresholds and the Diagnosis of Osteoporosis J. A. Kanis, E. V. McCloskey, N. C. Harvey, H. Johansson, W. D. Leslie
FRAX and fracture prediction without bone mineral density J. A. Kanis, N. C. Harvey, H. Johansson, A. Odén, W. D. Leslie, E. V. McCloskey
Quality of life, resource use, and costs related to hip fracture in Estonia M. Jürisson, H. Pisarev, J. Kanis, F. Borgström, A. Svedbom, R. Kallikorm, M. Lember, A. Uusküla
Is the Swedish FRAX model appropriate for Swedish immigrants? H. Johansson, A. Odén, M. Lorentzon, E. McCloskey, J. A. Kanis, N. C. Harvey, M. K. Karlsson, D. Mellström
FRAX predicts incident falls in elderly men: findings from MrOs Sweden N. C. Harvey, H. Johansson, A. Odén, M. K. Karlsson, B. E. Rosengren, Ö. Ljunggren, C. Cooper, E. McCloskey, J. A. Kanis, C. Ohlsson, D. Mellström
Trabecular bone score (TBS) as a new complementary approach for osteoporosis evaluation in clinical practice N. C. Harvey, C. C. Glüer, N. Binkley, E. V. McCloskey, M.-L. Brandi, C. Cooper, D. Kendler, O. Lamy, A. Laslop, B. M. Camargos, J.-Y. Reginster, R. Rizzoli, J. A. Kanis
FRAX and the effect of teriparatide on vertebral and non-vertebral fracture N. C. Harvey, J. A. Kanis, A. Odén, R. T. Burge, B. H. Mitlak, H. Johansson, E. V. McCloskey
Sarcopenia, the last organ insufficiency A. J. Cruz-Jentoft
Assessment of muscle mass, muscle strength and physical performance in clinical practice: An international survey O. Bruyère, C. Beaudart, J.-Y. Reginster, F. Buckinx, D. Schoene, V. Hirani, C. Cooper, J. A. Kanis, R. Rizzoli, E. McCloskey, T. Cederholm, A. Cruz-Jentoft, E. Freiberger
A New Concept of Health Can Improve the Definition of Frailty M. Boers, A. J. Cruz Jentoft
Frailty, Exercise and Nutrition J.-P. Michel, A. J. Cruz-Jentoft, T. Cederholm
Novel dysfunctional variant in ABCG2 as a cause of severe tophaceous gout: biochemical, molecular genetics and functional analysis B. Stiburkova, H. Miyata, J. Závada, M. Tomčík, K. Pavelka, G. Storkanova, Y. Toyoda, T. Takada, H. Suzuki
MRI assessment of suppression of structural damage in patients with rheumatoid arthritis receiving rituximab: results from the randomised, placebo-controlled, double-blind RA-SCORE study C. Peterfy, P. Emery, P. P. Tak, M. Østergaard, J. DiCarlo, K. Otsa, F. Navarro Sarabia, K. Pavelka, M.-A. Bagnard, L. Hinsch Gylvin, C. Bernasconi, A. Gabriele
Interleukin 35 Synovial Fluid Levels Are Associated with Disease Activity of Rheumatoid Arthritis L. Šenolt, B. Šumová, R. Jandová, H. Hulejová, H. Mann, K. Pavelka, J. Vencovský, M. Filková
Elevated serum prolactin levels as a marker of inflammatory arthritis in psoriasis vulgaris M. Husakova, J. Lippert, J. Stolfa, L. Sedova, P. Arenberger, Z. Lacinova, K. Pavelka
Diacerein: Benefits, Risks and Place in the Management of Osteoarthritis. An Opinion-Based Report from the ESCEO K. Pavelka, O. Bruyère, C. Cooper, J. A. Kanis, B. F. Leeb, E. Maheu, J. Martel-Pelletier, J. Monfort, J.-P. Pelletier, R. Rizzoli, J.-Y. Reginster
Development of EULAR recommendations for the reporting of clinical trial extension studies in rheumatology M. H. Buch, L. Silva-Fernandez, L. Carmona, D. Aletaha, R. Christensen, B. Combe, P. Emery, G. Ferraccioli, F. Guillemin, T. K. Kvien, R. Landewe, K. Pavelka, K. Saag, J. S. Smolen, D. Symmons, D. van der Heijde, J. Welling, G. Wells, R. Westhovens, A. Zink, M. Boers
A tailored approach to reduce dose of anti-TNF drugs may be equally effective, but substantially less costly than standard dosing in patients with ankylosing spondylitis over 1 year: a propensity score-matched cohort study J. Závada, M. Uher, K. Sisol, Š. Forejtová, K. Jarošová, H. Mann, J. Vencovský, K. Pavelka
A Study to Evaluate the Safety, Tolerability, and Efficacy of Brodalumab in Subjects with Rheumatoid Arthritis and an Inadequate Response to Methotrexate K. Pavelka, Y. Chon, R. Newmark, S.-L. Lin, S. Baumgartner, N. Erondu
Pain and analgesic use associated with skeletal-related events in patients with advanced cancer and bone metastases R. von Moos, J.-J. Body, B. Egerdie, A. Stopeck, J. Brown, L. Fallowfield, D. L. Patrick, C. Cleeland, D. Damyanov, F. Salvador Palazzo, G. Marx, Y. Zhou, A. Braun, A. Balakumaran, Y. Qian
Patients’ preferences for bone metastases treatments in France, Germany and the United Kingdom G. Hechmati, A. Brett Hauber, J. Arellano, A. F. Mohamed, Y. Qian, F. Gatta, I. Haynes, A. Bahl, R. von Moos, J.-J. Body
The role of denosumab in the prevention of hypercalcaemia of malignancy in cancer patients with metastatic bone disease I. J. Diel, J.-J. Body, A. T. Stopeck, S. Vadhan-Raj, A. Spencer, G. Stegerf, R. von Moos, F. Goldwasser, A. Feng, A. Braun
The role of biochemical of bone turnover markers in osteoporosis and metabolic bone disease: a consensus paper of the Belgian Bone Club E. Cavalier, P. Bergmann, O. Bruyère, P. Delanaye, A. Durnez, J.-P. Devogelaer, S. L. Ferrari, E. Gielen, S. Goemaere, J.-M. Kaufman, A. Nzeusseu Toukap, J.-Y. Reginster, A.-F. Rousseau, S. Rozenberg, A. J. Scheen, J.-J. Body
Hypocalcaemia in patients with metastatic bone disease treated with denosumab J.-J. Body, H. G. Bone, R. H. de Boer, A. Stopeck, C. Van Poznak, R. Damião, K. Fizazi, D. H. Henry, T. Ibrahim, A. Lipton, F. Saad, N. Shore, T. Takano, A. J. Shaywitz, H. Wang, O. L. Bracco, A. Braun, P. J. Kostenuik
Health resource utilization associated with skeletal-related events: results from a retrospective European study J.-J. Body, J. Pereira, H. Sleeboom, N. Maniadakis, E. Terpos, Y. P. Acklin, J. Finek, O. Gunther, G. Hechmati, T. Mossman, L. Costa, W. Rogowski, H. Nahi, R. von Moos
Targeting bone metastases in prostate cancer: improving clinical outcome J.-J. Body, S. Casimiro and L. Costa
Potential cost-effectiveness for using patient decision aids to guide osteoporosis treatment H. Penton, M. Hiligsmann, M. Harrison, J.-Y. Reginster, A. Boonen, N. Bansback
Cost-effectiveness of personalized supplementation with vitamin D-rich dairy products in the prevention of osteoporotic fractures O. Ethgen, M. Hiligsmann, N. Burlet, J.-Y. Reginster
The development of a personalized patient education tool for decision making for postmenopausal women with osteoporosis M. Hiligsmann, G. Ronda, T. van der Weijden, A. Boonen
Cost-effectiveness of vitamin D and calcium supplementation in the treatment of elderly women and men with osteoporosis M. Hiligsmann, W. B. Sedrine, O. Bruyère, S. M. Evers, V. Rabenda, J.-Y. Reginster
A Review of Patient Preferences for Osteoporosis Drug Treatment M. Hiligsmann, S. P. G. Bours, A. Boonen
Endocrine determinants of incident sarcopenia in middle-aged and elderly European men E. Gielen, T. W. O’Neill, S. R. Pye, J. E. Adams, F. C. Wu, M. R. Laurent, F. Claessens, K. A. Ward, S. Boonen, R. Bouillon, D. Vanderschueren, S. Verschueren
Bone demineralisation in a large cohort of Wilson disease patients K. H. Weiss, M. Van de Moortele, D. Nils Gotthardt, J. Pfeiffenberger, J. Seeßle, E. Ullrich, E. Gielen, H. Borghs, E. Adriaens, W. Stremmel, W. Meersseman, S. Boonen, D. Cassiman
Estrogens, the be-all and end-all of male hypogonadal bone loss? M. R. Laurent, E. Gielen, D. Vanderschueren
Chronic widespread pain is associated with worsening frailty in European men K. Fredrika Wade, D. M. Lee, J. McBeth, R. Ravindrarajah, E. Gielen, S. R. Pye, D. Vanderschueren, N. Pendleton, J. D. Finn, G. Bartfai, F. F. Casanueva, G. Forti, A. Giwercman, I. T. Huhtaniemi, K. Kula, M. Punab, F. C. W. Wu, T. W. O’Neill
Low heel ultrasound parameters predict mortality in men: results from the European Male Ageing Study (EMAS) S. R. Pye, D. Vanderschueren, S. Boonen, E. Gielen, J. E. Adams, K. A. Ward, D. M. Lee, G. Bartfai, F. F. Casanueva, J. D. Finn, G. Forti, A. Giwercman, T. S. Han, I. T. Huhtaniemi, K. Kula, M. E. Lean, N. Pendleton, M. Punab, F. C. Wu, T. W. O’Neill
Persistence, adherence, and medication-taking behavior in women with postmenopausal osteoporosis receiving denosumab in routine practice in Germany, Austria, Greece, and Belgium: 12-month results from a European non-interventional study P. Hadji, N. Papaioannou, E. Gielen, M. Feudjo Tepie, E. Zhang, I. Frieling, P. Geusens, P. Makras, H. Resch, G. Möller, L. Kalouche-Khalil, A. Fahrleitner-Pammer
Muscle-bone interactions: From experimental models to the clinic? A critical update M. R. Laurent, V. Dubois, F. Claessens, S. M. P. Verschueren, D. Vanderschueren, E. Gielen, F. Jardí
How to manage an isolated elevated PTH? J.-C. Souberbielle, E. Cavalier, C. Cormier
Serum PTH reference values established by an automated third-generation assay in vitamin D-replete subjects with normal renal function: consequences of diagnosing primary hyperparathyroidism and the classification of dialysis patients J.-C. Souberbielle, C. Massart, S. Brailly-Tabard, C. Cormier, E. Cavalier, P. Delanaye, P. Chanson
Serum calcitriol concentrations measured with a new direct automated assay in a large population of adult healthy subjects and in various clinical situations J.-C. Souberbielle, E. Cavalier, P. Delanaye, C. Massart, S. Brailly-Tabard, C. Cormier, D. Borderie, A. Benachi, P. Chanson
A Randomized, Double-Blind, Parallel Study to Evaluate the Dose-Response of Three Different Vitamin D Treatment Schemes on the 25-Hydroxyvitamin D Serum Concentration in Patients with Vitamin D Deficiency M.-L. Schleck, J.-C. Souberbielle, B. Jandrain, S. Da Silva, S. De Niet, F. Vanderbist, A. Scheen, Etienne Cavalier
Effects of cholecalciferol supplementation and optimized calcium intakes on vitamin D status, muscle strength and bone health: A one-year pilot randomized controlled trial in adults with severe burns A.-F. Rousseau, M. Foidart-Desalle, D. Ledoux, C. Remy, J.-L. Croisier, P. Damas, E. Cavalier
Sclerostin levels in CKD patients: an important, but not definitive, step on the way to clinical use P. Delanaye, E. Cavalier, A. Bouquegneau, A. Khwaja
Clinical and Biological Determinants of Sclerostin Plasma Concentration in Hemodialysis Patients P. Delanaye, J.-M. Krzesinski, X. Warling, M. Moonen, N. Smelten, L. Médart, O. Bruyère, J.-Y. Reginster, H. Pottel, E. Cavalier
Can we use circulating biomarkers to monitor bone turnover in CKD haemodialysis patients? Hypotheses and facts P. Delanaye, J.-C. Souberbielle, M.-H. Lafage-Proust, G. Jean, E. Cavalier
Evaluation of circulating irisin levels in healthy young individuals after a single 100,000 IU vitamin D dose E. Cavalier, V. Mismetti, J.-C. Souberbielle
Critical analytical evaluation of promising markers for sarcopenia E. Cavalier, C. Beaudart, F. Buckinx, O. Bruyère, J.-Y. Reginster
Standardization of DiaSorin and Roche automated third generation PTH assays with an International Standard: impact on clinical populations E. Cavalier, P. Delanaye, P. Lukas, A. Carlisi, R. Gadisseur, J.-C. Souberbielle
Inter-method variability in bone alkaline phosphatase measurement: Clinical impact on the management of dialysis patients E. Cavalier, J.-C. Souberbielle, R. Gadisseur, B. Dubois, J.-M. Krzesinski, P. Delanaye
EVALUATION OF THE INTRA-INDIVIDUAL VARIABILITY OF MYOSTATIN AND ACTIVIN A, TWO BIOMARKERS OF SARCOPENIA: IMPACT ON THE LEAST SIGNIFICANT CHANGE AND FOLLOWUP OF THE PATIENTS E. Cavalier, C. Piron, F. Watar, S. Kovacs, C. Beaudart, F. Buckinx, O. Bruyère, C. Le Goff, J.-Y. Reginster
Clinical trials of new drugs for the treatment of rheumatoid arthritis: focus on early disease J. S. Smolen, S. Collaud Basset, M. Boers, F. Breedveld, C. J. Edwards, T. K. Kvien, P. Miossec, T. Sokka-Isler, R. F. van Vollenhoven, E. C. Abadie, O. Bruyère, C. Cooper, H. Mäkinen, T. Thomas, P. Tugwell, J.-Y. Reginster, on behalf of the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO)
A consensus statement on the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) algorithm for the management of knee osteoarthritis - From evidence-based medicine to the real-life setting O. Bruyère, C. Cooper, J.-P. Pelletier, E. Maheu, F. Rannou, J. Branco, M. L. Brandi, J. A. Kanis, R. D. Altman, M. C. Hochberg, J. Martel-Pelletier, J.-Y. Reginster
A review of glucosamine for knee osteoarthritis: why patented crystalline glucosamine sulfate should be differentiated from other glucosamines to maximize clinical outcomes E. J. Kucharz, V. Kovalenko, S. Szántó, O. Bruyère, C. Cooper, J.-Y. Reginster
Aesthetic discomfort in hand osteoarthritis: results from the LIège Hand Osteoarthritis Cohort (LIHOC) A. Neuprez, O. Bruyère, E. Maheu, N. Dardenne, N. Burlet, P. D’Hooghe, S. Distèche, J.-Y. Reginster
Balancing benefits and risks of glucocorticoids in rheumatic diseases and other inflammatory joint disorders: new insights from emerging data. An expert consensus paper from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) C. Cooper, T. Bardin, M. L. Brandi, P. Cacoub, J. Caminis, R. Civitelli, M. Cutolo, W. Dere, J.-P. Devogelaer, A. Diez-Perez, T. A. Einhorn, P. Emonts, O. Ethgen, J. A. Kanis, J.-M. Kaufman, T. K. Kvien, W. F. Lems, E. McCloskey, P. Miossec, S. Reiter, J. Ringe, R. Rizzoli, K. Saag, J.-Y. Reginster
Cost-effectiveness of personalized supplementation with vitamin D-rich dairy products in the prevention of osteoporotic fractures O. Ethgen, M. Hiligsmann, N. Burlet, J.-Y. Reginster
Diacerein: Benefits, Risks and Place in the Management of Osteoarthritis. An Opinion-Based Report from the ESCEO K. Pavelka, O. Bruyère, C. Cooper, J. A. Kanis, B. F. Leeb, E. Maheu, J. Martel-Pelletier, J. Monfort, J.-P. Pelletier7, R. Rizzoli, J.-Y. Reginster
Effects of Dairy Products Consumption on Health: Benefits and Beliefs—A Commentary from the Belgian Bone Club and the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases S. Rozenberg, J.-J. Body, O. Bruyère, P. Bergmann, M. L. Brandi, C. Cooper, J.-P. Devogelaer, E. Gielen, S. Goemaere, J.-M. Kaufman, R. Rizzoli, J.-Y. Reginster
Effects of glucosamine on the use of rescue non-steroidal anti-inflammatory drugs in knee osteoarthritis: Results from the Pharmaco-Epidemiology of GonArthroSis (PEGASus) study L. C. Rovati, F. Girolami, M. D'Amato, G. Giacovelli
Efficacy and safety of glucosamine sulfate in the management of osteoarthritis: Evidence from real-life setting trials and surveys O. Bruyère, R. D. Altman, J.-Y. Reginster
Efficacy and safety of hyaluronic acid in the management of osteoarthritis: Evidence from real-life setting trials and surveys E. Maheu, F. Rannou, J.-Y. Reginster
Efficacy and safety of oral NSAIDs and analgesics in the management of osteoarthritis: Evidence from real-life setting trials and surveys J.-P. Pelletier, J. Martel-Pelletier, F. Rannou, C. Cooper
Efficacy and safety of topical NSAIDs in the management of osteoarthritis: Evidence from real-life setting trials and surveys F. Rannou, J.-P. Pelletier, J. Martel-Pelletier
Optimizing the management of osteoarthritis - Transitioning evidence-based guidelines into practical guidance for real-world clinical practice J.-Y. Reginster, C. Cooper
Osteoporosis and sarcopenia: two diseases or one? J.-Y. Reginster, C. Beaudart, F. Buckinx, O. Bruyère
Public health impact and cost-effectiveness of dairy products supplemented with vitamin D in prevention of osteoporotic fractures O. Ethgen, M. Hiligsmann, N. Burlet, J.-Y. Reginster
Recommendations for an update of the 2010 European regulatory guideline on clinical investigation of medicinal products used in the treatment of osteoarthritis and reflections about related clinically relevant outcomes: expert consensus statement J.-Y. Reginster, S. Reiter-Niesert, O. Bruyère, F. Berenbaum, M. L. Brandi, J. Branco, J.-P. Devogelaer, G. Herrero-Beaumont, J. A. Kanis, S. Maggi, E. Maheu, P. Richette, R. Rizzoli, C. Cooper
Recommendations for the conduct of clinical trials for drugs to treat or prevent sarcopenia J.-Y. Reginster, C. Cooper, R. Rizzoli, J. A. Kanis, G. Appelboom, I. Bautmans, H. A. Bischoff-Ferrari, M. Boers, M. L. Brandi1, O. Bruyère, A. Cherubini, B. Flamion, R. A. Fielding, A. Ildiko Gasparik, L. Van Loon, E. McCloskey, B. H. Mitlak, A. Pilotto, S. Reiter-Niesert, Y. Rolland, Y. Tsouderos, M. Visser, A. J. Cruz-Jentoft
The role of biochemical of bone turnover markers in osteoporosis and metabolic bone disease: a consensus paper of the Belgian Bone Club E. Cavalier, P. Bergmann, O. Bruyère, P. Delanaye, A. Durnez, J.-P. Devogelaer, S. L. Ferrari, E. Gielen, S. Goemaere, J.-M. Kaufman, A. Nzeusseu Toukap, J.-Y. Reginster, A.-F. Rousseau, S. Rozenberg, A. J. Scheen, J.-J. Body
The role of diet and exercise and of glucosamine sulfate in the prevention of knee osteoarthritis: Further results from the PRevention of knee Osteoarthritis in Overweight Females (PROOF) study J. Runhaar, R. Deroisy, M. van Middelkoop, F. Barretta, B. Barbetta, E. H. Oei, D. Vroegindeweij, G. Giacovelli, O. Bruyère, L. C. Rovati, J.-Y. Reginster, S. M. A. Bierma-Zeinstra
Recommendations for the conduct of clinical trials for drugs to treat or prevent sarcopenia J.-Y. Reginster, C. Cooper, R. Rizzoli, J. A. Kanis, G. Appelboom, I. Bautmans, H. A. Bischoff-Ferrari, M. Boers, M. L. Brandi, O. Bruyère, A. Cherubini, B. Flamion, R. A. Fielding, A. Ildiko Gasparik, L. Van Loon, E. McCloskey, B. H. Mitlak, A. Pilotto, S. Reiter-Niesert, Y. Rolland, Y. Tsouderos, M. Visser, A. J. Cruz-Jentoft
Public health impact and cost-effectiveness of dairy products supplemented with vitamin D in prevention of osteoporotic fractures O. Ethgen, M. Hiligsmann, N. Burlet, J.-Y. Reginster
Aesthetic discomfort in hand osteoarthritis: results from the LIège Hand Osteoarthritis Cohort (LIHOC) A. Neuprez, O. Bruyère, E. Maheu, N. Dardenne, N. Burlet, P. D’Hooghe, S. Distèche, J.-Y. Reginster
Recommendations for an update of the 2010 European regulatory guideline on clinical investigation of medicinal products used in the treatment of osteoarthritis and reflections about related clinically relevant outcomes: expert consensus statement J.-Y. Reginster, S. Reiter-Niesert, O. Bruyère, F. Berenbaum, M.-L. Brandi, J. Branco, J.-P. Devogelaer, G. Herrero-Beaumont, J. Kanis, S. Maggi, E. Maheu, P. Richette, R. Rizzoli, C. Cooper
Publication outcomes of the abstracts presented at the 2011 European Congress on Osteoporosis, Osteoarthritis and Musculo-Skeletal Diseases (ECCEO-IOF11) V. Rabenda, O. Bruyère, C. Cooper, R. Rizzoli, F. Buckinx, A. Quabron, J.-Y. Reginster
Comments on the discordant recommendations for the use of symptomatic slow acting drugs in knee osteoarthritis J.-Y. Reginster, C. Cooper, M. Hochberg, J.-P. Pelletier, R. Rizzoli, J. A. Kanis, E. Abadie, E. Maheu, M.-L. Brandi, J.-P. Devogelaer, J. Branco, G. Herrero-Beaumont, P. D’Hooghe, O. Bruyère
The ABC of writing a grant proposal E. Seeman
Effects of vitamin D in the elderly population: current status and perspectives O. Bruyère, E. Cavalier, J.-C. Souberbielle, H. A. Bischoff-Ferrari, C. Beaudart, F. Buckinx, J.-Y. Reginster, R. Rizzoli
The effects of vitamin D on skeletal muscle strength, muscle mass and muscle power: a systematic review and meta-analysis of randomized controlled trials C. Beaudart, F. Buckinx, V. Rabenda, S. Gillain, E. Cavalier, J. Slomian, J. Petermans, J.-Y. Reginster, O. Bruyère
Management of osteoporosis of the oldest old R. Rizzoli, J. Branco, M.-L. Brandi, S. Boonen, O. Bruyère, P. Cacoub, C. Cooper, A. Diez-Perez, J. Duder, R. A. Fielding, N. C. Harvey, M. Hiligsmann, J. A. Kanis, J. Petermans, J. D. Ringe, Y. Tsouderos, J. Weinman, J.-Y. Reginster
Antiresorptive Drugs Beyond Bisphosphonates and Selective Oestrogen Receptor Modulators for the Management of Postmenopausal Osteoporosis J. Y. Reginster, A. Neuprez, C. Beaudart, M. P. Lecart, N. Sarlet, D. Bernard, S. Disteche, O. Bruyere
Challenges for the Development of Bone-Forming Agents in Europe John A. Kanis, Rene Rizzoli, Cyrus Cooper, Jean-Yves Reginster
European Medicines Agency recommends that Protelos/Osseor remain available but with further restrictions European Medicines Agency
Dairy Products: How They Fit in Nutritionally Adequate Diets Edouard Clerfeuille, MSc; Matthieu Maillot, PhD; Eric O. Verger, MSc; Anne Lluch, PhD; Nicole Darmon, PhD; Nathalie Rolf-Pedersen, PhD
VIII CONGRESSO OrtoMed (SOCIETÀ ITALIANA DI ORTOPEDIA E MEDICINA Induzione alla)  
Genome-wide meta-analysis identifies 56 bone mineral density loci and reveals 14 loci associated with risk of fracture Karol Estrada, Unnur Styrkarsdottir, Evangelos Evangelou, Yi-Hsiang Hsu, Emma L Duncan, Evangelia E Ntzani, Ling Oei, Omar M E
European guidance for the diagnosis and management of osteoporosis in postmenopausal women J. A. Kanis, E. V. McCloskey, H. Johansson, C. Cooper, R. Rizzoli, J.-Y. Reginster
Assessing the Impact of Osteoporosis on the Burden of Hip Fractures Anders Odén, Eugene V. McCloskey, Helena JoJohansson, John A. Kanis
Treatment of osteoporosis in men J.-M. Kaufman, J.-Y. Reginster, S. Boonen, M.L. Brandi, C. Cooper, W. Dere, J.-P. Devogelaer, A. Diez-Perez, J.A. Kanis, E. McCloskey, B. Mitlak, E. Orwoll, J.D. Ringe, G. Weryha, R. Rizzoli
Incidence of Hip Fracture in Barranquilla, Colombia, and the Development of a Colombian FRAX Model J. J. Jaller-Raad, J. J. Jaller-Char, J. A. Lechuga-Ortiz, E. Navarro-Lechuga, H. Johansson, J. A. Kanis
Health Technology Assessment in Osteoporosis Mickael Hiligsmann, John A. Kanis, Juliet Compston, Cyrus Cooper, Bruno Flamion, Pierre Bergmann, Jean-Jacques Body, Steven Boonen, et al.
Standardising the descriptive epidemiology of osteoporosis: recommendations from the Epidemiology and Quality of Life Working Group of IOF J. A. Kanis, J. D. Adachi, C. Cooper, P. Clark, S. R. Cummings, M. Diaz-Curiel, N. Harvey, M. Hiligsmann, A. Papaioannou, D. D. Pierroz, S. L. Silverman, P. Szulc
Guideline for the diagnosis and management of osteoporosis in postmenopausal women and men from the age of 50 years in the UK: 2013 update National Osteoporosis Guideline Group, Kanis JA, McCloskey EV, Johansson H, Strom O, Borgstrom F, Oden A
Direct comparison of eight national FRAX® tools for fracture prediction and treatment qualification in Canadian women W. D. Leslie, S. L. Brennan, L. M. Lix, H. Johansson, A. Oden, E. McCloskey, J. A. Kanis
Mild morphometric vertebral fractures predict vertebral fractures but not non-vertebral fractures H. Johansson, A. Odén, E. V. McCloskey, J. A. Kanis
Quality of Life in Sarcopenia and Frailty René Rizzoli, Jean-Yves Reginster, Jean-François Arnal, Ivan Bautmans, Charlotte Beaudart, Heike Bischoff-Ferrari, Emmanuel Biver, Steven Boonen, Maria-Luisa Brandi, Arkadi Chines, Cyrus Cooper, Sol Epstein, Roger A. Fielding, Bret Goodpaster, John A. Kanis, Jean-Marc Kaufman, Andrea Laslop, Vincenzo Malafarina, Leocadio Rodriguez Mañas, Bruce H. Mitlak, Richard O. Oreffo, Jean Petermans, Kieran Reid, Yves Rolland, Avan Aihie Sayer, Yannis Tsouderos, Marjolein Visser, Olivier Bruyère
Tools in the Assessment of Sarcopenia C. Cooper, R. Fielding, M. Visser, L. J. van Loon, Y. Rolland, E. Orwoll, K. Reid, S. Boonen, W. Dere, S. Epstein, B. Mitlak, Y. Tsouderos, A. A. Sayer, R. Rizzoli, J. Y. Reginster, J. A. Kanis
What is the predictive value of MRI for the occurrence of knee replacement surgery in knee osteoarthritis? J-P Pelletier, C Cooper, C Peterfy, J-Y Reginster, M-L Brandi, O Bruyère, R Chapurlat, F Cicuttini, P G Conaghan, M Doherty, H Genant, G Giacovelli, M C Hochberg, D J Hunter, J A Kanis, M Kloppenburg, J-D Laredo, T McAlindon, M Nevitt, J-P Raynauld, R Rizzoli, C Zilkens, F W Roemer, J Martel-Pelletier, A Guermazi
Development and application of FRAX in the management of osteoporosis in Ireland BMcGowan, John A. Kanis, H. Johansson, C. Silke, B. Whelan
Vitamin D supplementation in elderly or postmenopausal women: a 2013 update of the 2008 recommendations from the European Society for Clinical and Economics Aspects of Osteoporosis and Osetoarthritis (ESCEO) R. Rizzoli, S. Boonen, M.-L. Brandi, O. Bruyère, C. Cooper, J.A. Kanis, J.-M. Kaufman, J.D. Ringe, G. Weryha, J.-Y. Reginster
Worldwide uptake of FRAX J. A. Kanis, H. Johansson, A. Oden, C. Cooper, E. V. McCloskey
Drugs for bone healing Maria Luisa Brandi
Socioeconomic Burden of Total Joint Arthroplasty for Symptomatic Hip and Knee Osteoarthritis in the Italian Population: A 5-Year Analysis Based on Hospitalization Records P. PISCITELLI, G. IOLASCON, G. DI TANNA, E. BIZZI, G. CHITANO, A. ARGENTIERO, C. NEGLIA, L. GIOLLI, A. DISTANTE, R. GIMIGLIANO, M. L. BRANDI, AND ALBERTO MIGLIORE
Assessment of Gene-by-Sex Interaction Effect on Bone Mineral Density Ching-Ti Liu, Karol Estrada, Laura M Yerges-Armstrong, Najaf Amin, Evangelos Evangelou, Guo Li, Ryan L Minster, Melanie A Carless, Candace M Kammerer, Ling Oei, Yanhua Zhou, Nerea Alonso, Zoe Dailiana, Joel Eriksson, Natalia Garci´a-Giralt, Sylvie Giroux, Lise Bjerre Husted, Rita I Khusainova, Theodora Koromila, Annie WaiChee Kung, Joshua R Lewis, Laura Masi.........
When the government actively faces the burden of osteoporosis: the Italian experience Maria Luisa Brandi, Giuseppe Guglielmi, Salvatore Masala, Salvatore Minisola, Sergio Ortolani, Umberto Tarantino, Giovanni Simonetti
Updated fracture incidence rates for the Italian version of FRAX® P. Piscitelli, G. Chitano, H. Johannson, M. L. Brandi, J. A. Kanis, D. M. Black
Assessing the risk of osteonecrosis of the jaw due to bisphosphonate therapy in the secondary prevention of osteoporotic fractures F. Lapi, F. Cipriani, A. P. Caputi, G. Corrao, A. Vaccheri, M. C. Sturkenboom, M. Di Bari, D. Gregori, F. Carle, T. Staniscia, A. Vestri, M. Brandi, V. Fusco, G. Campisi, G. Mazzaglia, on behalf of the Bisphosphonates Efficacy-Safety Tradeoff (BEST) study group
Denosumab Densitometric Changes Assessed by Quantitative Computed Tomography at the Spine and Hip in Postmenopausal Women With Osteoporosis Michael R. McClung, Jose R. Zanchetta, Arne Høiseth, David L. Kendler, Chui Kin Yuen, Jacques P. Brown, Sigitas Stonkus, Stefan Goemaere, Chris Recknor, Grattan C. Woodson, Michael A. Bolognese, Edward Franek, Maria Luisa Brandi, Andrea Wang, and Cesar Libanati
Denosumab Significantly Increases DXA BMD at Both Trabecular and Cortical Sites: Results From the FREEDOM Study Michael A. Bolognese, Christence Stubbe Teglbjærg, Jose R. Zanchetta, Kurt Lippuner, Michael R. McClung, Maria Luisa Brandi, Arne Høiseth, Peter Lakatos, Alfred H. Moffett, Roman S. Lorenc, Andrea Wang, and Cesar Libanati
Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards S. Vasikaran, R. Eastell, O. Bruyère, A. J. Foldes, P. Garnero, A. Griesmacher, M. McClung, H. A. Morris, S. Silverman, T. Trenti, D. A. Wahl, C. Cooper, J. A. Kanis, for the IOF-IFCC Bone Marker Standards Working Group
Osteoporosis: burden, health care provision and opportunities in the EU O. Ström, F. Borgström, John A. Kanis, Juliet Compston, Cyrus Cooper, Eugene V. McCloskey, Bengt Jönsson
Subtrochanteric fractures after long-term treatment with bisphosphonates: a European Society on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis, and International Osteoporosis Foundation Working Group Report R. Rizzoli, K. Åkesson, M. Bouxsein, J. A. Kanis, N. Napoli, S. Papapoulos, J.-Y. Reginster, C. Cooper
Validation of the IOF quality of life questionnaire for patients with wrist fracture P. Lips, K. Jameson, M. L. Bianchi, S. Goemaere, S. Boonen, J. Reeve, J. Stepan, O. Johnell, N. M. van Schoor, E. Dennison, J. A. Kanis, C. Cooper, Working Group for Quality of Life of the International Osteoporosis Foundation
A framework for the development of guidelines for the management of glucocorticoid-induced osteoporosis S. Lekamwasam, J. D. Adachi, D. Agnusdei, J. Bilezikian, S. Boonen, F. Borgström, C. Cooper, A. Diez Perez, R. Eastell, L. C. Hofbauer, J. A. Kanis, B. L. Langdahl, O. Lesnyak, R. Lorenc, E. McCloskey, O. D. Messina, N. Napoli, B. Obermayer-Pietsch, S. H. Ralston, P. N. Sambrook, S. Silverman, M. Sosa, J. Stepan, G. Suppan, D. A. Wahl, J. E. Compston, Joint IOF-ECTS GIO Guidelines Working Group
European guidance for the diagnosis and management of osteoporosis in postmenopausal women J. A. Kanis, N. Burlet, C. Cooper, P. D. Delmas, J.-Y. Reginster, F. Borgstrom, R. Rizzoli
Interpretation and use of FRAX in clinical practice J. A. Kanis, D. Hans, C. Cooper, S. Baim, J. P. Bilezikian, N. Binkley, J. A. Cauley, J. E. Compston, B. Dawson-Hughes, G. El-Hajj Fuleihan, H. Johansson, W. D. Leslie, E. M. Lewiecki, M. Luckey, A. Oden, S. E. Papapoulos, C. Poiana, R. Rizzoli, D. A. Wahl, E. V. McCloskey, Task Force of the FRAX Initiative
European guidance for the diagnosis and management of osteoporosis in postmenopausal women J. A. Kanis, E. V. McCloskey, H. Johansson, C. Cooper, R. Rizzoli, J.-Y. Reginster
Intrauterine growth and postnatal skeletal development: findings from the Southampton Women’s Surveyppe_1237 Nicholas C. Harvey, Pam A. Mahon, Miranda Kim, Zoe A. Cole, Sian M. Robinson, Kassim Javaid, Hazel M. Inskip, Keith M. Godfrey, Elaine M. Dennison, Cyrus Cooper, and the SWS Study Group
Different Indices of Fetal Growth Predict Bone Size and Volumetric Density at 4 Years of Age Nicholas C. Harvey, Pamela A. Mahon, Sian M. Robinson, Corrine E. Nisbet, M. Kassim Javaid, Sarah R. Crozier, Hazel M. Inskip, Keith M. Godfrey, Nigel K. Arden, Elaine M. Dennison, Cyrus Cooper, and the SWS Study Group
Evaluation of Methylation Status of the eNOS Promoter at Birth in Relation to Childhood Bone Mineral Content Nicholas C. Harvey, Karen A. Lillycrop, Emma Garratt, Allan Sheppard, Cameron McLean, Graham Burdge, Jo Slater-Jefferies, Joanne Rodford, Sarah Crozier, Hazel Inskip, Bright Starling Emerald, Catharine R. Gale, Mark Hanson, Peter Gluckman, Keith Godfrey, Cyrus Cooper
Physical activity, calcium intake and childhood bone mineral: a population-based cross-sectional study N. C. Harvey, Z. A. Cole, S. R. Crozier, M. Kim, G. Ntani, L. Goodfellow, S. M. Robinson, H. M. Inskip, K. M. Godfrey, E. M. Dennison, N. Wareham, U. Ekelund, C. Cooper
Development and validation of a disease model for postmenopausal osteoporosis A. Gauthier, J. A. Kanis, M. Martin, J. Compston, F. Borgström, C. Cooper, E. McCloskey
Treatment failure in osteoporosis A. Diez-Perez, J. D. Adachi, D. Agnusdei, J. P. Bilezikian, J. E. Compston, S. R. Cummings, R. Eastell, E. F. Eriksen, J. Gonzalez-Macias, U. A. Liberman, D. A. Wahl, E. Seeman, J. A. Kanis, C. Cooper
Secular trends in the incidence of hip and other osteoporotic fractures C. Cooper, Z. A. Cole, C. R. Holroyd, S. C. Earl, N. C. Harvey, E. M. Dennison, L. J. Melton, S. R. Cummings, J. A. Kanis
Long-term treatment of osteoporosis in postmenopausal women: a review from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) and the International Osteoporosis Foundation (IOF) C. Cooper, J.-Y. Reginster, B. Cortet, M. Diaz-Curiel, R.S. Lorenc, J.A. Kanis, R. Rizzoli
A fully automated system for quantification of knee bone marrow lesions using MRI and the osteoarthritis initiative cohort Pierre Dodin, François Abram, Jean-Pierre Pelletier, Johanne Martel-Pelletier
Future therapeutics for osteoarthritis Johanne Martel-Pelletier, Lukas M. Wildi, Jean-Pierre Pelletier
Reliability and sensitivity to change of IW-TSE versus DESS magnetic resonance imaging sequences in the assessment of bone marrow lesions in knee osteoarthritis patients: Longitudinal data from the Osteoarthritis Initiative (OAI) cohort Jean-Pierre Raynauld, Lukas Martin Wildi, François Abram, Thomas Moser, Jean-Pierre Pelletier, Johanne Martel-Pelletier
Biologics and the Cardiovascular System: A Double-Edged Sword Camille Roubille, Johanne Martel-Pelletier, Boulos Haraoui, Jean-Claude Tardif and Jean-Pierre Pelletier
Osteoarthritis treatments: where do we stand at the moment? Camille Roubille, Johanne Martel-Pelletier, Jean-Pierre Pelletier
Assessment of Cartilage Changes Over Time in Knee Osteoarthritis Disease-Modifying Osteoarthritis Drug Trials Using Semiquantitative and Quantitative Methods: Pros and Cons Lukas MAartin Wildi, Johanne Martel-Pelletier, François Abram, Thomas Moser, Jean-Pierre Raynauld, and Jean-Pierre Pelletier
How to define responders in osteoarthritis C. Cooper, J.D. Adachi, T. Bardin, F. Berenbaum, B. Flamion, H. Jonsson, J. A. Kanis, F. Pelousse, W. F. Lems, J.-P. Pelletier, J. Martel-Pelletier, S. Reiter, J.-Y. Reginster, R. Rizzoli, O. Bruyère
Efficacy and safety of strontium ranelate in the treatment of knee osteoarthritis: results of a double-blind, randomised placebo-controlled trial J.-Y. Reginster, J. Badurski, N. Bellamy, W. Bensen, R. Chapurlat, X. Chevalier, C. Christiansen, H. Genant, F. Navarro, E. Nasonov, P. N. Sambrook, T. D. Spector, C. Cooper
Understanding Osteoarthritis From Bench to Bedside Martel-Pelletier, J., Pelletier, J-P.: Editors, In
A fully automated human knee 3D MRI bone segmentation using the ray casting technique Dodin, P., Martel-Pelletier, J., Pelletier, J-P., Abram, F.
Strontium ranelate inhibits key factors affecting bone remodelling in human osteoarthritic subchondral bone osteoblasts Tat, S.K., Pelletier, J-P., Mineau, F., Caron, J., Martel-Pelletier, J.
Risk factors predictive of joint replacement in a two-year multicentre clinical trial in knee osteoarthritis using MRI: results from over six years of observation Raynauld, J-P., Martel-Pelletier, J., Haraoui, B., Choquette, D., Dorais, M., Wildi, L.M., Abram, F., Pelletier, J-P. for the Canadian Licofelone Study Group.
Chondroitin sulphate reducesoth cartilage volume loss and bone marrow lesions in knee OA patients starting as early as 6 months after initiation of therapy: a randomized, double-blind, placebo controlled pilot study using MRI Wildi, L.M., Raynauld, J-P., Martel-Pelletier, J., Beaulieu, A., Bessette, L., Morin F., Abram, F., Dorais, M., Pelletier J-P.
Trends in Hip Fracture Incidence and in the Prescription of Antiosteoporosis Medications During the Same Time Period in Belgium (2000-2007) M. Hiligsmann, O. Bruyère, D. Roberfroid, C. Dubois, Yves Parmentier, J. Carton, J. Detilleux, P. Gillet, J.-Y. Reginster
Assessing 5-year incidence rates and determinants of osteoporotic fractures in primary care F. Lapia, M. Simonettib, R. Michieli, A. Pasqua, M.L. Brandi, B. Frediani, C. Cricelli, G. Mazzaglia
Genetic architecture of hand quantitative ultrasound measures: A population-based study in a Sardinian genetic isolate G. Biino, L. Casula, F. de Terlizzi, M. Adamo, S. Vaccargiu, M. Francavilla, D. Loi, A. Casti, M. Atzori, M. Cosso, F. Marras, C. Cepollaro, M. L. Brandi, M. Pirastu
Genetic Determinants of Osteoporosis: Common Bases to Cardiovascular Diseases? F. Marini, M. L. Brandi
Paget's disease of bone: there's more than the affected skeletal--a clinical review and suggestions for the clinical practice. A. Falchetti, L. Masi, M. L. Brandi
Pharmacogenetics of bisphosphonate-associated osteonecrosis of the jaw F. Marini, P. Tonelli, L. Cavalli, T. Cavalli, L. Masi, A. Falchetti, M. L. Brandi
Pharmacogenetics of osteoporosis F. Marini, M. L. Brandi
What is a good patient reported outcome after total hip replacement? N.K. Arden, A. Kiran, A. Judge, L.C. Biant, M.K. Javaid, D.W. Murray, A.J. Carr, C. Cooper, R.E. Field
Does birthweight predict bone mass in adulthood? A systematic review and meta-analysis. J. Baird, M. A. Kurshid, M. Kim, N. Harvey, E. Dennison, C. Cooper
Facilitated transporters mediate net efflux of amino acids to the fetus across the basal membrane of the placental syncytiotrophoblast J. K. Cleal, J. D. Glazier, G. Ntani, S. R. Crozier, P. E. Day, N. C. Harvey, S. M. Robinson, C. Cooper, K. M. Godfrey, M. A. Hanson, R. M. Lewis
Increased fat mass is associated with increased bone size but reduced volumetric density in pre pubertal children Z.A. Cole, N.C. Harvey, M. Kim, G. Ntani, S.M. Robinson, H.M. Inskip, K.M. Godfrey, C. Cooper, E.M. Dennison, The Southampton Women's Survey Study Group
Objective measures of physical capability and subsequent health: a systematic review R. Cooper, D. Kuh, C. Cooper, C. R. Gale, D. A. Lawlor, F. Matthews, R. Hardy, The Falcon and Halcyon Study Teams
Secular trends in the incidence of hip and other osteoporotic fractures C. Cooper, Z. A. Cole, C. R. Holroyd, S. C. Earl, N. C. Harvey, E. M. Dennison, L. J. Melton, S. R. Cummings, J. A. Kanis, The IOF CSA Working Group on Fracture Epidemiology
Epigenetic influences in the developmental origins of osteoporosis C. Holroyd, N. Harvey, E. Dennison, C. Cooper
Growth in childhood predicts hip fracture risk in later life M. K. Javaid, J. G. Eriksson, E. Kajantie, T. Forsén, C. Osmond, D. J. P. Barker, C. Cooper
Coordinator-based systems for secondary prevention in fragility fracture patients D. Marsh, K. Akesson, D. E. Beaton, E. R. Bogoch, S. Boonen, M.-L. Brandi, A. R. McLellan, P. J. Mitchell, J. E. M. Sale, D. A. Wahl, IOF CSA Fracture Working Group
Association of vitamin D status with knee pain and radiographic knee osteoarthritis S. Muraki, E. Dennison, K. Jameson, B.J. Boucher, T. Akune, N. Yoshimura, A. Judge, N.K. Arden, K. Javaid, C. Cooper
Use of proton pump inhibitors and risk of hip/femur fracture: a population-based case-control study S. Pouwels, A. Lalmohamed, P. Souverein, C. Cooper, B. J. Veldt, H. G. Leufkens, A. de Boer, T. van Staa, F. de Vries
Bisphosphonate use and risk of post-operative fracture among patients undergoing a total knee replacement for knee osteoarthritis: a propensity score analysis D. Prieto-Alhambra, M. K. Javaid, A. Judge, J. Maskell, A. Kiran, C. Cooper, N. K. Arden
Changes in hip fracture rate before and after total knee replacement due to osteoarthritis: a population-based cohort study D. Prieto-Alhambra, M. K. Javaid, J. Maskell, A. Judge, M. Nevitt, C. Cooper, N. K. Arden
Fracture Risk Before and After Total Hip Replacement in Patients With Osteoarthritis D. Prieto-Alhambra, M. K. Javaid, A. Judge, J. Maskell, A. Kiran, F. de Vries, C. Cooper, N. K. Arden
Subtrochanteric fractures after long-term treatment with bisphosphonates: a European Society on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis, and International Osteoporosis Foundation Working Group Report R. Rizzoli, K. Akesson, M. Bouxsein, J. A. Kanis, N. Napoli, S. Papapoulos, J.-Y. Reginster, C. Cooper
Failure to perceive increased risk of fracture in women 55 years and older: the Global Longitudinal Study of Osteoporosis in Women (GLOW) E. S. Siris, S. Gehlbach, J. D. Adachi, S. Boonen, R. D. Chapurlat, J. E. Compston, C. Cooper, P. Delmas, A. Díez-Pérez, F. H. Hooven, A. Z. LaCroix, J. C. Netelenbos, J. Pfeilschifter, M. Rossini, C. Roux, K. G. Saag, P. Sambrook, S. Silverman, N. B. Watts, A. Wyman, S. L. Greenspan
Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards S. Vasikaran, R. Eastell, O. Bruyère, A. J. Foldes, P. Garnero, A. Griesmacher, M. McClung, H. A. Morris, S. Silverman, T. Trenti, D. A. Wahl, C. Cooper, J. A. Kanis, for the IOF-IFCC Bone Marker Standards Working Group
Life course body mass index and risk of knee osteoarthritis at the age of 53 years: evidence from the 1946 British birth cohort study A. K. Wills, S. Black, R. Cooper, R. J. Coppack, R. Hardy, K. Remmes Martin, C. Cooper, D. Kuh
A FRAX® model for the assessment of fracture probability in Belgium H. Johansson, J. A. Kanis, E. V. McCloskey, A. Odén, J.-P. Devogelaer, J.-M. Kaufman,A. Neuprez, M. Hiligsmann, O. Bruyere, J.-Y. Reginster
Adverse Reactions and Drug-Drug Interactions in the Management of Women with Postmenopausal Osteoporosis R. Rizzoli, J.-Y. Reginster, S. Boonen, G. Bréart, A. Diez-Perez, D. Felsenberg, J.-M. Kaufman, J. A. Kanis, C. Cooper
Biomarkers and personalised medicine in rheumatoid arthritis: a proposal for interactions between academia, industry and regulatory bodies P. Miossec, C. L. Verweij, L. Klareskog, C. Pitzalis, A. Barton, F. Lekkerkerker, S. Reiter, A. Laslop, F. Breedveld, E. Abadie, B. Flamion, W. Dere, S. Mpofu, N. Goel, D. Ethgen, B. Mitlak, S. Ormarsdóttir, R. Rao, Y. Tsouderos, J.-Y. Reginster; on behalf of the Group for the Respect of Ethics and Excellence in Science (GREES)
The potential impact of new National Osteoporosis Foundation guidance on treatment patterns B. Dawson-Hughes, A. C. Looker,A. N. A. Tosteson, H. Johansson, J. A. Kanis, L. J. Melton III
Automatic Human Knee Cartilage Segmentation From 3-D Magnetic Resonance Images P. Dodin, J.-P. Pelletier, J. Martel-Pelletier, F. Abram
Development and validation of a disease model for postmenopausal osteoporosis A. Gauthier, J. A. Kanis, M. Martin, J. Compston, F. Borgström, C. Cooper, E. McCloskey; On behalf of the Committee of Scientific Advisors, International Osteoporosis Foundation
FRAX - modell för att beräkna 10-årsrisken för fraktur H. Johansson, J. A. Kanis, Ö. Ljunggren, O. Ström, O. Svensson, D. Mellström
Osteoporosis J. A. Kanis
Case finding for the management of osteoporosis with FRAX®-assessment and intervention thresholds for the UK J. A. Kanis, E. V. McCloskey, H. Johansson, O. Ström, F. Borgström, A. Oden, National Osteoporosis Guideline Group
Guidance for the adjustment of FRAX according to the dose of glucocorticoids J. A. Kanis, H. Johansson, A. Oden, E. V. McCloskey
Development and use of FRAX® in osteoporosis J. A. Kanis, E. V. McCloskey, H. Johansson, A. Oden, O. Strom, F. Borgstrom
Osteoporosis - Clinical Review J. A. Kanis, E. V. McCloskey
Towards a diagnostic and therapeutic consensus in male osteoporosis J. A. Kanis, G. Bianchi, J. P. Bilezikian, J.-M. Kaufman, S. Khosla, E. Orwoll, E. Seeman
Targeting subchondral bone for treating osteoarthritis: what is the evidence? S. Kwan Tat, D. Lajeunesse, J.-P. Pelletier, J. Martel-Pelletier.
Spine-hip discordance and fracture risk assessment: a physician-friendly FRAX enhancement W. D. Leslie, L. M. Lix, H. Johansson, A. Oden, E. McCloskey, J. A. Kanis
Independent Clinical Validation of a Canadian FRAX Tool: Fracture Prediction and Model Calibration W. D. Leslie, L. M. Lix, H. Johansson, A. Oden, E. V. McCloskey, J. A. Kanis for the Manitoba Bone Density Program
Hip fracture risk in older US adults by treatment eligibility status based on new National Osteoporosis Foundation guidance A. C. Looker, B. Dawson-Hughes, A. N. A. Tosteson, H. Johansson, J. A. Kanis, L. J. Melton III
Decrease in serum level of matrix metalloproteinases is predictive of the disease-modifying effect of osteoarthritis drugs assessed by quantitative MRI in patients with knee osteoarthritis J.-P. Pelletier, J.-P. Raynauld, J. Caron, F. Mineau, F. Abram, M. Dorais, B. Haraoui, D. Choquette, J. Martel-Pelletier
Risk factors predictive of joint replacement in a 2-year multicentre clinical trial in knee osteoarthritis using MRI: results from over 6 years of observation J.-P. Raynauld, J. Martel-Pelletier, B. Haraoui, D. Choquette, M. Dorais, L. M. Wildi, F. Abram, J.-P. Pelletier; for the Canadian Licofelone Study Group
Adverse Reactions and Drug-Drug Interactions in the Management of Women with Postmenopausal Osteoporosis R. Rizzoli, J.-Y. Reginster, S. Boonen, G. Bréart, A. Diez-Perez, D. Felsenberg, J.-M. Kaufman, J. A. Kanis, C. Cooper
Strontium ranelate inhibits key factors affecting bone remodeling in human osteoarthritic subchondral bone osteoblasts S. Kwan Tat, J.-P. Pelletier, F. Mineau, J. Caron, J. Martel-Pelletier
Hondroitin sulphate reduces both cartilage volume loss and bone marrow lesions in knee osteoarthritis patients starting as early as 6 months after initiation of therapy: a randomised, double-blind, placebo-controlled pilot study using MRI L. M. Wildi, J.-P. Raynauld, J. Martel-Pelletier, A. Beaulieu, L. Bessette, F. Morin, F. Abram, M. Dorais, J.-P. Pelletier
Assessment of health claims in the field of bone: a view of the Group for the Respect of Ethics and Excellence in Science (GREES) O. Bruyère, R. Rizzoli, V. Coxam, B. Avouac, T. Chevalier, V. Fabien-Soulé, J. A. Kanis, J.-M. Kaufman, Y. Tsouderos, J.-Y. Reginster
The need for a transparent, ethical, and successful relationship between academic scientists and the pharmaceutical industry: a view of the Group for the Respect of Ethics and Excellence in Science (GREES) O. Bruyère, J. A. Kanis, M.-E. Ibar-Abadie, N. Alsayed, M. L. Brandi, N. Burlet, D. L. Cahall, A. Chines, J.-P. Devogelaer, W. Dere, N. Goel, N. Hughes, J.-M. Kaufman, S. Korte, B. H. Mitlak, D. Niese, R. Rizzoli, L. C. Rovati, J.-Y. Reginster
Loading and Skeletal Development and Maintenance P. Bergmann, J. J. Body, S. Boonen, Y. Boutsen, J.-P. Devogelaer, S. Goemaere, J. Kaufman, J.-Y. Reginster, S. Rozenberg
Recommendations for an update of 2003 European regulatory requirements for registration of drugs to be used in the treatment of RA J. S. Smolen, M. Boers, E. C. Abadie, F. C. Breedveld, P. Emery, T. Bardin, N. Goel, D. J. Ethgen, B. P. Avouac, W. H. Dere, P. Durez, M. Matucci-Cerenic, B. Flamion, A. Laslop
Medication Compliance and Persistence: Terminology and Definitions J. A. Cramer, A. Roy, A. Burrell, C. J. Fairchild, M. J. Fuldeore, D. A. Ollendorf, P. K. Wong
A Competing Risks Prescription Refill Model of Compliance and Persistence T. I. Barron, K. Bennett, J. Feely
Evidence-based guidelines for the pharmacological treatment of postmenopausal osteoporosis: a consensus document by the Belgian Bone Club J.-J Body, P. Bergmann, S. Boonen, Y. Boutsen, J.-P. Devogelaer, S. Goemaere, J.-M. Kaufman, S. Rozenberg, J.-Y. Reginster
Osteonecrosis of the jaw and bisphosphonate treatment for osteoporosis R. Rizzoli, N. Burlet, D. Cahall, P. D. Delmas, E. F. Eriksen, D. Felsenberg, J. Grbic, M. Jontell, R. Landesberg, A. Laslop, M. Wollenhaupt, S. Papapoulos, O. Sezer, M. Sprafka, J.-Y. Reginster
The role of calcium and vitamin D in the management of osteoporosis R. Rizzoli, S. Boonen, M.-L. Brandi, N. Burlet, P. Delmas, J.-Y. Reginster
European regulatory perspectives for innovative therapies S. Ormarsdottir, J.-Y. Reginster, E. Abadie
Evaluation of symptomatic slow-acting drugs in osteoarthritis using the GRADE system O. Bruyère, N. Burlet, P. D. Delmas, R. Rizzoli, C. Cooper and J.-Y. Reginster
Recommendations for the registration of agents for prevention and treatment of glucocorticoid-induced osteoporosis: an update from the Group for the Respect of Ethics and Excellence in Science J. Compston, D.M. Reid, J. Boisdron, M.-L. Brandi, N. Burlet, D. Cahall, P.D. Delmas, W. Dere, J.-P. Devogelaer, L.A. Fitzpatrick, B. Flamion, N. Goel, S. Korte, A. Laslop, B. Mitlak, S. Ormarsdottir, J. Ringe, R. Rizzoli, Y. Tsouderos, T. Van Staa, J.-Y. Reginster
Loss of hip bone mineral density over time is associated with spine and hip fracture incidence in osteoporotic postmenopausal women O. Bruyere, A. R. Varela, S. Adami, J. Detilleux, V. Rabenda, M. Hiligsmann, J.-Y. Reginster
Treatment of osteoporosis: recognizing and managing cutaneous adverse reactions and drug-induced hypersensitivity P. Musette, M. L. Brandi, P. Cacoub, J. M. Kaufman, R. Rizzoli, J.-Y. Reginster
Management of osteoporosis in the elderly R. Rizzoli, O. Bruyere, J. B. Cannata-Andia, J.-P. Devogelaer, G. Lyritis, J. D. Ringe, B. Vellas, J.-Y. Reginster
Post-fracture management of patients with hip fracture: a perspective O. Bruyere, M.-L. Brandi, N. Burlet, N. Harvey, G. Lyritis, H. Minne, S. Boonen, J.-Y. Reginster, R. Rizzoli and K. Akesson
European guidance for the diagnosis and management of osteoporosis in postmenopausal women J. A. Kanis, N. Burlet, C. Cooper, P. D. Delmas, J.-Y. Reginster, F. Borgstrom, R. Rizzoli
Adherence to bisphosphonates therapy and hip fracture risk in osteoporotic women V. Rabenda, R. Mertens, V. Fabri, J. Vanoverloop, F. Sumkay, C. Vannecke, A. Deswaef, G. A. Verpooten, J.-Y. Reginster
Adherence to treatment of osteoporosis: a need for study F. Lekkerkerker, J. A. Kanis, N. Alsayed, G. Bouvenot, N. Burlet, D. Cahall, A. Chines, P. Delmas, R.-L. Dreiser, D. Ethgen, N. Hughes, J.-M. Kaufman, S. Korte, G. Kreutz, A. Laslop, B. Mitlak, V. Rabenda, R. Rizzoli, A. Santora, R. Schimmer, Y. Tsouderos, P. Viethel, J.-Y. Reginster
Clinical evaluation of medicinal products for acceleration of fracture healing in patients with osteoporosis J. Goldhahn, W. H. Scheele, B. Mitlak, E. Abadie, P. Aspenberg, P. Augat, M.-L. Brandi, N. Burlet, A. Chines, P. D. Delmas, I. Dupin-Roger, D. Ethgen, B. Hanson, F. Hartl, J. Kanis, R. Kewalramani, A. Laslop, D. Marsh, S. Ormarsdottir, R. Rizzoli, A. Santora, G. Schmidmaier, M. Wagener, J.-Y. Reginster
Critical Issues in Translational and Clinical Research for the Study of New Technologies to Enhance Bone Repair J. Goldhahn, B. Mitlak P. Aspenberg, J. Kanis, R. Rizzoli, J.-Y. Reginster
Low Incidence of Anti-Osteoporosis Treatment After Hip Fracture V. Rabenda, J. Vanoverloop, V. Fabri, R. Mertens, F. Sumkay, C. Vannecke, A. Deswaef, G. A. Verpooten, J.-Y. Reginster
Poor adherence to oral bisphosphonate treatment and its consequences: a review of the evidence V. Rabenda, M. Hiligsmann, J.-Y. Reginster
Positive impact of compliance to strontium ranelate on the risk of nonvertebral osteoporotic fractures V. Rabenda, J.-Y. Reginster
Recommendations for an update of the current (2001) regulatory requirements for registration of drugs to be used in the treatment of osteoporosis in postmenopausal women and in men J.-Y. Reginster, E. Abadie, P. Delmas, R. Rizzoli, W. Dere, P. der Auwera, B. Avouac, M.-L. Brandi, A. Daifotis, A. Diez-Perez, G. Calvo, O. Johnell, J.-M. Kaufman, G. Kreutz, A. Laslop, F. Lekkerkerker, B. Mitlak, P. Nilsson, J. Orloff, M. Smillie, A. Taylor, Y. Tsouderos, D. Ethgen, B. Flamion
Therapeutic Adherence with Bisphosphonates in the Treatment of Osteoporosis V. Rabenda, J.-Y. Reginster
Loss of hip bone mineral density over time is associated with spine and hip fracture incidence in osteoporotic postmenopausal women O. Bruyere, A. R. Varela, S. Adami, J. Detilleux,V. Rabenda, M. Hiligsmann, J.-Y. Reginster
Biologic therapies and bone loss in rheumatoid arthritis C. A. F. Zerbini_P. Clark_L. Mendez-Sanchez_R. M. R. Pereira_O. D. Messina_C. R. Uña_J. D. Adachi_W. F. Lems_C. Cooper_N. E. Lane_on behalf IOF CIBS Working Group.
Validation of the SarQoL®, a specific health-related quality of life questionnaire for Sarcopenia Charlotte Beaudart, Emmanuel Biver, Jean-Yves Reginster, René Rizzoli, Yves Rolland, Ivan Bautmans, Jean Petermans, Sophie Gillain, Fanny Buckinx, Nadia Dardenne, Olivier Bruyère
Physical function measurements predict mortality in ambulatory older men Stefanie L. De Buyser, Mirko Petrovic, Youri E. Taes, Kaatje R. C. Toye, Jean-Marc Kaufman and Stefan Goemaere
Three year functional changes and long-termmortality hazard in community-dwelling older men Stefanie De Buyser, Mirko Petrovic, Youri Taes, Kaatje Toye, Jean-Marc Kaufman, Stefan Goemaere, Bruno Lapauw
Validation of the FNIH sarcopenia criteria and SOF frailty index as predictors of long-term mortality in ambulatory older men Stefanie L. De Buyser, Mirko Petrovic, Youri E. Taes, Kaatje R. C. Toye, Jean-Marc Kaufman, Bruno Lapauw, Stefan Goemaere
Unmet needs and current and future approaches for osteoporotic patients at high risk of hip fracture Serge Ferrari, Jean-Yves Reginster, Maria Luisa Brandi, John A. Kanis Jean-Pierre Devogelaer, Jean-Marc Kaufman, Jean-Marc Féron, Andreas Kurth, René Rizzoli
Vitamin D status correction in Saudi Arabia: an experts' consensus under the auspices of the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis, and Musculoskeletal Diseases (ESCEO) Nasser M. Al-Daghri, Yousef Al-Saleh, Naji Aljohani, Riad Sulimani, Abdulaziz M. Al-Othman, Hanan Alfawaz, Mona Fouda, Fahad Al-Amri, Awad Shahrani, Mohammed Alharbi, Fahad Alshahrani, Waleed Tamimi, Shaun Sabico,Rene Rizzoli Jean-Yves Reginster

 

OTHER FILES


DOWNLOAD TITLE AUTHORS
IOF WCO - ECCEO10 / ECCEO11-IOF / IOF-ECCEO12 Visual Microsoft Powerpoint file.